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Escherichia coli is an extensively used model organism in molecular biology as well as an 
important human commensal and a versatile pathogen causing a repertoire of intestinal and 
extraintestinal infections. The pathogenic potential of E. coli is strongly influenced by 
laterally transferred genes, and pathogenic E. coli isolates are classified into distinct 
pathovars on the basis of the disease symptoms and the infection route. Molecular genetics 
and genomic studies have identified four main phylogenetic groups in the E. coli species; the 
extraintestinal isolates of E. coli cluster mainly into the B2 phylogroup, whereas 
diarrheagenic E. coli isolates are found in various phylogenetic groups. Distribution of 
virulence and fitness genes in E. coli phylogroups and pathovars has been extensively 
studied, but our knowledge on possible differences in gene regulation within specific groups 
of E. coli remains limited. It is however becoming apparent that evolutionary adaptation to 
pathogenic lifestyles involves, in addition to gain and loss of genes, changes in the 
expression of fitness genes found both in pathogenic and commensal E. coli. In this work, I 
investigated phylogenetic group -associated differences in promoter architecture and 
regulation of a conserved adhesin of E. coli, the Mat fimbria, and analyzed biological 
functions of this common organelle. 
 
The Mat fimbria is encoded by the mat (or ecp) gene cluster, which is prevalent and 
conserved in the published genomes of E. coli. The biological functions of Mat and the 
regulatory mechanisms controlling the mat genes differ in E. coli isolates from different 
sources, and a basis for the regulatory differences was here described. This study identified 
the Mat fimbria as a novel determinant for temperature-dependent biofilm formation in E. 
coli. The mat operon was expressed in vitro in Luria-Bertani broth exclusively by the 
isolates of the B2 phylogroup, and the mat expression was induced by low growth 
temperature, by acidic pH, and by elevated levels of acetate. Extensive genetic studies and 
analysis of a well-described strain collection revealed that the differential mat expression is 
due to phylogroup-associated variation in the structure of the mat upstream regulatory DNA. 
Three regulatory genes, matA, hns, and rcsB, that participate in the transcriptional and post-
transcriptional regulation of the mat operon were identified. Notably, these regulators form a 
network that reciprocally coordinates two opposite functions, Mat fimbriae-mediated 
adherence and flagella-driven motility.  
 
The mat operon is an early acquisition in the evolution of E. coli and has been maintained 
during evolution of the E. coli groups. This thesis work presents a model for intra-species 
divergent evolution of regulatory DNA that supports phenotypic diversity within a bacterial 
species. The findings give an example of pathoadaptive variation in a regulatory DNA that 





1.1 Escherichia coli – a friend and a foe  
The Gram-negative, rod-shaped bacterium Escherichia coli, originally called Bacterium coli 
commune, was first isolated from feces of a healthy infant in 1885 by Theodor Escherich 
(Escherich, 1885). E. coli has been the subject of intense research for over a century. 
Nowadays it is by far the best-studied bacterium and most extensively used model organism 
and laboratory workhorse in molecular biology. E. coli is an ecological generalist that 
inhabits various vertebrata including mammals, birds, reptiles, and fish (Clermont et al., 
2008; Escobar-Páramo et al., 2006). However, E. coli is predominantly isolated from 
mammals (Gordon & Cowling, 2003) and in fact represents the most common member of 
the family Enterobacteriaceae in the mammalian lower intestinal tract (Gordon & 
FitzGibbon, 1999). E. coli is also widely distributed in the environment and capable of 
surviving in soil, water and sediment (Ishii et al., 2006; Power et al., 2005; Savageau M.A., 
1983; Walk et al., 2007). In humans, the majority of E. coli isolates are commensals of the 
lower intestinal tract (Tenaillon et  al., 2010), but E. coli also includes life-threatening, 
pathogenic strains that are responsible for diseases in the gut, urinary tract, bloodstream, and 
central nervous system (Croxen & Finlay, 2010; Kaper et al., 2004).  
 
The genus Escherichia belongs to the family Enterobacteriaceae of  the  
Gammaproteobacteria that also includes Salmonella, from which Escherichia diverged 
about the time of the emergence of mammals, 120-160 million years ago (Ochman & 
Wilson, 1987). The genus consists of three named species, E. coli (the type species for the 
genus), Escherichia fergusonii (Farmer et al., 1985), and Escherichia albertii (Huys et al., 
2003), as well as five phylogenetically distinct, cryptic clades that are genetically divergent 
from E. coli on the basis of multi-locus sequence typing (MLST) and whole-genome 
phylogenetic analysis (Luo et al., 2011; Walk et al., 2009). The available data indicate that 
the cryptic clades represent environmentally adapted bacteria that primarily live outside the 
host intestinal tract (Ingle et  al., 2011; Walk et  al., 2009). Shigella and Escherichia are 
generally treated as separate genera. The genetically very closely related Shigella spp. 
(Shigella boydii, Shigella dysenteriae, Shigella flexneri, and Shigella soneii) have adopted an 
intracellular lifestyle (Ray et al., 2009) and are the causative agents of bacillary dysentery or 
shigellosis. Based on phylogenetic analyses, the invasive Shigella are specialized pathogenic 
strains of E. coli rather than separate species (Lan et al., 2004; Pupo et al., 1997; Pupo et al., 
2000). The genus status of Shigella has been retained largely because of their distinct clinical 
presentation and importance as pathogens.  
 
E. coli strains are phenotypically heterogeneous, and isolates that share particular features 
have been divided into subgroups on various criteria. As early as in the 1940’s, certain 
clinical manifestations were found to be associated with specific serological variants of E. 
coli (Bray, 1945). In 1947 Kauffman proposed an antigenic scheme for E. coli serotypes on 
the basis of expression of three types of surface antigens, the lipopolysaccharide (O), capsule 
(K), and flagellum (H) (Kauffmann, 1947). Since then, at least 173 O, 80 K, and 56 H 
antigens have been recognized (Ørskov & Ørskov, 1992), and several hundred E. coli 
serotypes have been described. However, only a small percentage of these serotypes has 
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been implicated in pathogenesis of E. coli. On the basis of distinct pathogenic schemes, 
pathogenic E. coli are separated from commesal isolates into different categories, pathovars, 
that are capable of causing disease in healthy individuals. Only to a limited extent, serotypic 
markers correlate with specific pathovars. In addition to serotyping, phylogenetic grouping 
of E. coli strains by multilocus enzyme electrophoresis, MLST or multiplex PCR are popular 
ways to categorize E. coli strains.  
1.1.1 E. coli as a commensal 
Human physiology and health is fully dependent on microbes that outnumber the total 
number of human cells in the adult body by tenfold (O'Hara & Shanahan, 2006). Dynamic 
interactions between the microbiota, the intestinal epithelium, and the host immune system 
maintain mucosal homeostasis and are essential for mounting protective immunity to 
invading microorganisms (Artis, 2008; Hooper & Macpherson, 2010). Microbes also provide 
metabolic capabilities important for the human host, such as cleavage of dietary 
polysaccharides, synthesis of short-chain fatty acids (SCFAs), and production of essential 
amino acids and vitamins. From the approximately 100 trillion (1014) microbial cells in the 
human body, vast majority reside in the gastrointestinal tract (Savage, 1977). This microbial 
community, the human gut microbiota, is comprised of mostly bacteria, and recent 
metagenomic sequencing data from fecal samples of 124 European individuals suggest that 
this community is composed of more than 1,000 bacterial species (Qin et al., 2010). The 
composition of human microbiota varies remarkably across body habitats (Costello et  al., 
2009), including the different intestinal sites (Hayashi et al., 2005), and from individual to 
individual (Eckburg et al., 2005; Turnbaugh et al., 2009).  
 
Development of the microbiota commences during birth. From an essentially sterile state at 
birth, the body becomes rapidly colonized within hours by microbes that originate from the 
mother's vaginal, fecal and skin microbiota, from the living environment, and from handling 
by other individuals. E. coli and other facultatively anaerobic species are among the first 
colonizers of the oxygenous gastrointestinal tract of newborns (Rotimi & Duerden, 1981; 
Stark & Lee, 1982), and they are commonly transmitted to the infants from the mother by an 
oral route (Bettelheim et al., 1974; Bettelheim & Lennox-King, 1976; de Muinck et al., 
2011). Analysis of fecal samples from over thousand infants at the age of one month showed 
that the prevalence of E. coli is 88% in humans (Penders et al., 2006). During the first 
months of life the gut progressively becomes more reduced and acifidied, which favours the 
growth of obligately anaerobic bacteria, mainly Bifidobacterium and Bacteroides. After a 
series of successions of bacterial communities, facultatives decline in numbers and the gut 
microbiota attains its adult-like composition dominated by obligate anaerobes (Palmer et al., 
2007). In healthy adults, the numbers of anaerobic bacteria in the intestine are 100-1000 fold 
over those of aerobic bacteria (Hoogkamp-Korstanje et al., 1979) and the intestinal 
microbiota is dominated by two bacterial phyla, the Gram-negative Bacteroidetes and the 
Gram-positive Firmicutes, which make up over 90% of the known phylotypes (Eckburg et 
al., 2005; Ley et al., 2008; Qin et al., 2010). E. coli is able to persist as a resident member of 
the normal microbiota of the large intestine, especially in the caecum and the colon, from 
infancy to adulthood. It also frequently colonizes vaginal and endocervical mucosal surfaces 
(Guiral et al., 2011; Gupta et al., 1998; Krohn et al., 1997; Obata-Yasuoka et al., 2002; Watt 
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et al., 2003). E. coli is considered an important and widespread human commensal 
(Tenaillon et al., 2010) that benefits the host by inducing colonization resistance to invading 
pathogens (Freter & Abrams, 1972; Hudault et al., 2001; Leatham et al., 2009; Schamberger 
et al., 2004; Schultz, 2008). 
1.1.2 E. coli as a pathogen 
E. coli also is significant from the perspective of human and animal health because it is 
capable of causing a wide range of severe intestinal and extraintestinal infections (Croxen & 
Finlay, 2010; Kaper et al., 2004). It is believed to kill more than two million humans 
annually. Indeed, pathogenic E. coli is a leading cause of diarrhea-associated deaths 
worldwide and accounts in developing countries for 30 to 40 percent of acute diarrhea in 
children under the age of five (O'Ryan et al., 2005). E. coli also is the predominant causative 
agent of Gram-negative neonatal meningitis and responsible for a third of the cases of 
neonatal meningitis (Gaschignard et al., 2011). Moreover, the species has significant 
economic impacts as being the most common cause of uncomplicated urinary tract infection 
(UTI) (Gaynes et al., 2005; Gupta et al., 1999; Warren, 1996). 
 
Pathogenic E. coli strains capable of causing disease in healthy humans are classified into 
eight well-defined pathovars on the basis of the symptoms they cause and their infection 
route as well as possession of virulence traits (Croxen & Finlay, 2010; Kaper et al., 2004). 
The six extensively studied diarrheagenic pathovars of E. coli, also designated intestinal 
pathogenic E. coli (IPEC), are enteropathogenic E. coli (EPEC), enterohaemorrhagic E. coli 
(EHEC), enterotoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC), enteroaggregative 
E. coli (EAEC), and diffusely adherent E. coli (DAEC).  IPECs  are  obligate  pathogens.  In  
contrast to diarrheagenic isolates, extraintestinal E. coli (ExPEC) strains can benignly inhabit 
the intestine. The properly defined ExPEC pathovars implicated in extraintestinal infections 
in humans are uropathogenic E. coli (UPEC) and neonatal meningitis E. coli (NMEC). 
Besides the above-mentioned pathovars, there are several additional, less characterized E. 
coli pathovars (Kaper et al., 2004), such as Crohn's disease-associated adherent-invasive E. 
coli (AIEC; Boudeau et  al., 1999) and avian pathogenic E. coli (APEC; Dho-Moulin & 
Fairbrother, 1999), responsible for colibacillosis in poultry. Most of the E. coli pathovars 
described above are not highly invasive and rarely cause a systemic infection in adult 
humans. 
 
Pathogenic E. coli isolates possess a spectrum of virulence-associated factors that enable 
them to colonize and cause disease and to manifest distinct features in pathogenesis (Croxen 
& Finlay, 2010). Such virulence factors include adhesins, invasins, toxins, iron-acquisition 
systems, and host defense-avoidance mechanisms to attack crucial intracellular pathways in 
their hosts and to subvert host defences and other important cellular functions.  
1.1.3 Neonatal meningitis E. coli isolates 
NMEC is one of the leading causative agents of neonatal meningitis, an inflammation of the 
meninges in newborn infants. NMEC and group B Streptococcus account for over 80% of 
cases of neonatal bacterial meningitis in industrialized countries. Despite advances in 
antibiotics and infant intensive care, the disease continues to be associated with high rates of 
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mortality and permanent sequelae in survivors worldwide. Mortality is about 10% to 15% in 
industrialized countries, whereas in developing countries the rate is notably higher, in the 
range of 40%–58% (Furyk et al., 2011; Gaschignard et al., 2011). NMEC strains are 
genetically closely related and distributed only in few serotypes (Bonacorsi & Bingen, 
2005), and strains possessing the K1 capsule antigen are predominant (80-88%) among 
isolates from neonatal E. coli meningitis (Bingen et al., 1997; Johnson et al., 2002; 
Korhonen et al., 1985; Robbins et al., 1974). K1 is mostly associated with O18 antigen 
(Johnson et al., 2002; Korhonen et al., 1985; Sarff et al., 1975), and the common and 
worldwide distributed O18:K1:H7 clone represents the most studied serotype. NMEC strains 
are closely related to a subset of APEC and UPEC strains and there is no definite host- or 
pathovar-specific virulence gene pattern among these groups (Bauchart et al., 2010; Ewers et 
al., 2007; Moulin-Schouleur et al., 2006; Moulin-Schouleur et al., 2007). Thus, poultry may 
be a food-borne source of ExPEC strains causing disease in humans, and APEC isolates 
constitutes a high zoonotic risk and a reservoir for virulence-associated genes of human 
ExPEC (Tivendale et  al., 2010). In adults, E. coli K1  strains  are  often  members  of  the  
normal microflora (Obata-Yasuoka et al., 2002; Sarff et al., 1975), and they are able to 
induce meningitis only in exceptional conditions, such as neurosurgery and trauma. 
However, vertical transmission of NMEC from the microbiota of the maternal genital tract to 
the infant is considered as a main mode of acquisition of NMEC (Sarff et al., 1975), hence 
ability to colonize the female genital tract is an aspect of NMEC pathogenesis. 
 
The multiplication in bloodstream is a critical early phase of the K1 infection and a key step 
in the pathogenesis of the bacterial meningitis. NMEC gains access to the bloodstream by 
direct hematogenous spread, or by crossing the mucosal barrier and entering the bloodstream 
after ingestion and colonization of the host intestinal mucosa (Glode et al., 1977; Pluschke et 
al., 1983; Zelmer et al., 2008). A high degree of bacteraemia (>103 colony-forming units/ml) 
is a prerequisite for a penetration of NMEC across the blood-brain barrier (Dietzman et al., 
1974; Kim et al., 1992), which is characterized by a microvascular endothelial cells with 
tight junctions (Rubin & Staddon, 1999). Similar linkage between the magnitude of 
bacteremia and the crossing the blood–brain barrier has been observed for group B 
Streptococcus, S. pneumoniae, and Haemophilus influenzae type b (Ferrieri et al., 1980; 
Moxon & Ostrow, 1977; Sullivan et  al., 1982). The development of E. coli K1 meningitis 
correlates  with  the  age  of  the  host,  and  the  greatest  risk  of  acquiring  meningitis  is  in  the  
neonatal period (<28 days) (Korhonen et al., 1985; Unhanand et al., 1993). Neonates have 
deficiencies in each of the major arms of the immune system, including cellular, humoral 
and innate immunity. It has been suggested that the age dependency of E. coli meningitis 
results from the ability of E. coli K1  to  evade  the  immature  host  defenses  to  achieve  the  
threshold level of bacteraemia rather than differences between neonates and adults in host 
tissue interactions with E. coli (Stins et al., 1999). After binding to and transmigration 
through brain microvascular endothelial cells in an enclosed vacuole without intracellular 
multiplication (Prasadarao et al., 1999) into the central nervous system, NMEC multiplies in 
the cerebrospinal fluid and ceases expression of the K1 capsule (Zelmer et al., 2008). The 
bacterial growth elicits inflammatory responses from the host, eventually leading to 




Several bacterial factors have been recognized to contribute to the development of E. coli 
meningitis in neonates. One of the most important virulence factor is the K1 capsule, a linear 
homopolymer of α-2,8-linked polysialic acid that is structurally identical to the 
meningococcal B capsular polysaccharide (Troy, 1992). The K1 capsule is protective antigen 
of NMEC that confers serum resistance and an antiphagocytic barrier to the bacterium (Allen 
et al., 1987; Bortolussi et al., 1983; Cross et al., 1986; Mittal & Prasadarao, 2008). It also 
prevents lysosomal fusion in microvascular endothelial cells when crossing the blood-brain 
barrier (Kim et al., 2003). Notable, Finne (1982) reported the presence of large amounts of 
α-2,8-linked polysialic acid in developing mammalian brain tissue, and the expression was 
shown to be associated predominantly with neural cell adhesion molecules (NCAM; Finne et 
al., 1983; Hoffman et al., 1982). Thus, neonatal immune responses to E. coli K1 are likely to 
be restricted due to molecular mimicry of the polysialic acid capsule to polysialic acid 
epitope of NCAM on fetal neuronal tissue (Troy, 1992). Efficient replication in bloodstream 
also demands iron acquisition systems, such as IroN and aerobactin (Khan & Isaacson, 2002; 
Nègre et al., 2004), and surface expression of OmpA which binds C4b-binding protein 
(C4bp) and thereby inhibits classical complement pathway (Wooster et al., 2006). OmpA 
also binds to brain vascular endothelium (Prasadarao et al., 1996; Prasadarao, 2002), induces 
survival in macrophages (Sukumaran et al., 2004) as well as prevents maturation of dendritic 
cells (Mittal & Prasadarao, 2008). In addition, multiple adhesion and invasion proteins and 
protein  complexes  such  as  S  fimbria,  type  1  fimbria,  flagellum,  type  III  secretion  system,  
IbeA, and CNF1 have been associated with NMEC penetration into brain microvascular 
endothelial cells (Huang et al., 1995; Huang et al., 2000; Khan & Isaacson, 2002; Parkkinen 
et al., 1988b; Parthasarathy et al., 2007; Teng et al., 2005; Yao et al., 2009). Although the 
bacterial factors mentioned have shed some light on the mechanisms of the development of 
NMEC infections, the pathophysiology of E. coli neonatal meningitis is still rather unclear 
(Kim, 2003; Kim, 2008), and a more complete understanding of pathogenic determinants of 
NMEC strains is required for prevention of this complex and multistage disease. 
1.1.4 Genome dynamics and evolution of E. coli 
The recent large outbreak of severe hemolytic uremic syndrome and bloody diarrhoea in 
Germany caused by Shiga toxin-producing E. coli O104:H4, an exceptionally virulent hybrid 
of EAEC and EHEC (Brzuszkiewicz et al., 2011; Mellmann et al., 2011), highlights the fact 
that E. coli is constantly evolving and able to cause new health threats and mayhem. Behind 
the phenotypic variety of E. coli is an exceptional genomic plasticity, illustrated by the large 
diversity in genome sizes within the species, even greater than 25% (Bergthorsson & 
Ochman, 1998; Dobrindt et  al.,  2003).  Since  the  publication  of  the  first  complete  E. coli 
genome sequence in 1997 for the nonpathogenic E. coli K-12 isolate MG1655 (Blattner et 
al., 1997), 51 fully sequenced E. coli genomes, representing different pathovars and 
commensals and varying in size from 4.6 to 6.2 Mb, have been released. In addition, 984 
currently ongoing projects await completion (http://www.genomesonline.org). Analyses of 
the genome content and the genome organization of different isolates have revealed that E. 
coli genomes have a mosaic-like structure composed of a conserved part, i.e. the core genes 
present in all E. coli genomes, and a variable part, the so-called flexible gene pool or pan-
genome (Dobrindt et al., 2010; Welch et al., 2002). The core genome possesses the genetic 
information required for essential cellular processes, whereas the pan-genome consists of 
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e.g. genomic or pathogenicity islands (GEIs, PAIs) and accessory genetic elements 
(plasmids, transposons, integrons, insertion sequence elements, prophages) and provides 
additional properties for adaptation to unique environments. The pan-genome of E. coli 
contains approximately 18,000 genes, and a typical genome of an E. coli is comprised of 
about 5,000 genes of which less than 2,000 are conserved in all isolates (Lukjancenko et al., 
2010; Rasko et al., 2008; Touchon et al., 2009).   
 
The ability to remodel genetic repertoire by repeated acquiring and losing large 
chromosomal regions as well as by DNA rearrangements and point mutations has a key 
impact on the border between commensalism and pathogenicity, i.e. the evolution of 
pathogenic E. coli variants (Ahmed et al., 2008; Dobrindt, 2005; Dobrindt et al., 2010). In E. 
coli, the rate of recombination exceeds the mutation rate by 50-100 folds (Guttman & 
Dykhuizen, 1994; Touchon et al., 2009). The frequent and widespread recombination within 
the species drives the clonal divergence. In addition, the E. coli genome is particularly 
permissive to lateral gene transfer, an important mechanism to rapidly exchange genetic 
information between different bacteria by transformation, transduction, and conjugation, and 
harbours regulatory systems that assimilate foreign genes into pre-existing regulatory 
networks (Dobrindt et al., 2010). In a pioneering study, Lawrence and Ochman (1998) 
estimated that 18% of the genome of the K-12 strain MG1655 consists of laterally 
transferred genes, acquired in over 200 separate events since its divergence from Salmonella. 
Most of the gene flux takes place at particular regions of high instability, the integration 
hotspots, and the well-known hotspots of gene acquisition, tRNA genes, counts only a minor 
fraction of these (Touchon et al., 2009). Virulence factors are frequently encoded by genes 
located on mobile DNA elements, and therefore the pathogenic potential of E. coli is 
strongly influenced by laterally transferred genes. Current dogma suggests that pathogenic 
variants can rapidly evolve from their  commensal ancestors by lateral  transfer of blocks of 
genes that provide a repertoire of novel traits in a single step. For example, the hallmark of 
the evolution of Shigella is the acquisition a large 210 kb plasmid that encodes primary 
virulence determinants for entry into epithelial cells, intracellular replication and 
dissemination from cell to cell (Venkatesan et al., 2001). Strains with the same pathotype, 
including Shigella clones, have arisen independently and repeatedly in several lineages as a 
result of lateral acquisition of genes (Lacher et al., 2007; Lan et al., 2004; Ogura et al., 2009; 
Pupo et  al., 2000; Reid et al., 2000; Sims & Kim, 2011; Turner et al., 2006; Wirth et al., 
2006). In addition to lateral gene transfer, also loss and inactivation of genes shape the 
genomes of E. coli isolates. Nonvirulent strains can originate from pathogenic E. coli by 
reductive evolution and virulence attenuation (Zdziarski et al., 2008). The currently used 
probiotic fecal strain Nissle 1917 (Mutaflor®) and the probiotic-like asymptomatic 
bacteriuria (ABU) strain 83972 share common ancestor with the highly virulent UPEC strain 
CFT073 and exemplify deconstructed pathogens (Vejborg et al., 2010). 
 
Despite the massive flux of genes and the genomic plasticity, the population structure of E. 
coli remains largely clonal (Ochman & Selander, 1984; Selander & Levin, 1980; Selander et 
al., 1986; Touchon et al., 2009). Based on population genetic studies, E. coli strains cluster 
into four major phylogenetic groups (designated A, B1, D, and B2) along with two minor 
groups (E and F) (Clermont et al., 2000; Herzer et al., 1990; Tenaillon et al., 2010). Group 
A and B2 isolates are generally predominant in humans; however socioeconomic, climatic, 
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and geographic factors have impact on the prevalence of phylogenetic groups among 
different human populations (Tenaillon et al., 2010; White et al., 2011). Each phylogenetic 
group contains varying proportions of non-pathogens and different pathogroups. The 
majority of commensal strains are members of the group A and B1, whereas human ExPEC 
strains cluster mostly into group B2 and to a lesser extent group D (Bingen et al., 1998; 
Duriez et al., 2001; Escobar-Páramo et al., 2004; Moulin-Schouleur et al., 2007; Picard et 
al., 1999). In contrast, diarrheagenic strains are found throughout the phylogeny, though 
those associated with severe and acute diarrhoea lie outside groups B2 and D (Escobar-
Páramo et al., 2004). Several studies suggest that the B2 group is the ancestral phylogenetic 
group of E. coli (Escobar-Páramo et  al., 2004; Lecointre et al., 1998; Sims & Kim, 2011). 
The members of the group exhibit the highest genetic diversity (Touchon et al., 2009) and 
their genetic background favors acquisition and expression of the laterally acquired genes 
(Escobar-Páramo et al., 2004). Moreover, the B2 strains are well adapted for asymptomatic 
human colonization (Moreno et  al., 2009; Nowrouzian et al., 2005; Obata-Yasuoka et  al., 
2002; Watt et al., 2003; Zhang et al., 2002). This indicates that the normal microbiota is an 
important reservoir for ExPEC strains. 
1.2 Fimbriae of E. coli 
E. coli expresses a multitude of cell surface proteins and their complexes that interact with 
host and environmental surfaces. The adhesion to surfaces is a prerequisite for bacterial 
colonization. In microbial pathogenesis, the specific adhesion of the pathogen to host surface 
receptors is an important determinant in tissue tropism and promotes the pathogen’s ability 
to resist mechanical defences, thereby enabling propagation and the initiation of pathological 
processes. The functional parts of the adhesins are often localized in peripheral regions of 
the cell wall (Donnenberg, 2000). Enteric bacteria frequently express their adhesins on thin 
filamentous protein appendages, referred to as fimbriae (according to Duguid et al., 1955; 
latin for ‘fibre’) or pili (according to Brinton, 1959; latin for ‘hair’), that extend out from the 
cell surface, beyond possible capsular and lipopolysaccharide layers, and represent the 
predominating adhesin type studied in Gram-negative bacteria. Houwink and van Iterson 
(1950) as well as Duguid et al. (1955) demonstrated the presence of fimbriae in E. coli as 
early as the 1950s, and many fimbrial types have subsequently been identified (reviewed in 
Klemm et al., 2010; Korea et al., 2011), but nevertheless our knowledge of them is still 
limited and many are poorly characterized, especially the receptors involved in their 
recognition. All fimbriae do not display adhesive properties; some fimbrial appendages have 
specialized roles in DNA or protein transport involved in bacterial conjugation or injection 
of virulence factors into the host cell (Fronzes et al., 2008). 
1.2.1 Structure and assembly of fimbriae 
A fimbriated bacterial cell generally has a multitude of, up to several hundreds, fimbriae 
distributed peritrichously over the entire surface of the bacterium (Edwards & Puente, 1998); 
however, some fimbriae are expressed in a polar orientation (Girón et al., 1991). Because of 
their abundance on the cell surface, structural fimbrial components are attractive targets for 
vaccine development and the prevention of bacterial infections. Fimbriae of Gram-negative 
bacteria are formed by the noncovalent association of hundreds of helical assembled 
fimbrillins into long filamentous rod-like, or coiled, surface protein polymers, usually 1-2 
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µm in length and 5–10 nm in diameter (Proft & Baker, 2009). By contrast, the fimbrial 
subunits of Gram-positive bacteria are covalently linked to each other and to the 
peptidoglycan cell wall through the formation of intermolecular isopeptide bonds by specific 
sortases (Hendrickx et al., 2011; Scott & Zähner, 2006). In addition to the repeating major 
subunit proteins, the fimbrial filament contains a few (or several) minor subunits both in 
Gram-negative and Gram-positive bacteria. In Gram-negative bacteria the adhesive potential 
of fimbriae is commonly mediated by the properties of the adhesin molecule located at the 
distal end of the filament. However, in some fimbrial types the major subunit can play both a 
structural and an adhesive role (Bakker et al., 1992; Jacobs et al., 1987; Jansson et al., 2006; 
Van Loy et al., 2002). The adhesion properties also depend on the quaternary structure of the 
fimbrial filament, particularly when the fimbriated bacterium is exposed to strong 
hydrodynamic shear forces (Duncan et al., 2005; Forero et al., 2006). Recent force-
measuring optical tweezer analyses on a single fimbria level have revealed that the 
quaternary architecture of helix-like fimbriae permits repeated elongation (5–7 times of the 
fimbrial length) and contraction of the filament. The flexibility increases the ability of a 
bacterium to withstand shear forces and allows a redistribution of shear stress over a number 
of fimbriae (Andersson et al., 2008; Axner et al., 2011). 
 
The adhesive fimbriae of Gram-negative bacteria are classified into four major assembly 
pathways on the basis of their assembly mechanism: the chaperone-usher (CU) pathway, the 
extracellular nucleation/precipitation pathway (curli), the alternate chaperone pathway (CS 
fimbriae) and type IV pathway (Fronzes et  al., 2008; Nuccio & Bäumler, 2007; Soto & 
Hultgren, 1999). These pathways, with the exception of type IV, utilize the general secretion 
pathway (Sec-pathway) for translocation of fimbrial subunits across the inner membrane. 
The unfolded subunit proteins are targeted to the Sec-translocase by their cleavable N-
terminal signal sequence. In contrast, type IV fimbriae assembly does not involve 
periplasmic intermediates; the subunits are exported from the cytoplasm to the extracellular 
environment in one step via an assembly machinery that spans both inner and outer 
membranes. Of the four classes, the CU fimbriae form the most abundant group of bacterial 
cell surface filaments and are the most extensively characterized. On the basis of the amino 
acid sequences of the outer membrane usher protein, the CU family comprises at least 189 
members that are divided into six major phylogenetic clades termed α-, β-, γ-, κ-, π-, and σ-
fimbriae (Nuccio & Bäumler, 2007). In this pathway, the translocated periplasmic subunits 
form complexes with specific chaperone proteins that assist in protein folding by completing 
the  Ig-like  fold  of  subunits  with  its  donor  β-strand,  prevent  premature  assembly  of  the  
subunits, and transport the subunits to an outer-membrane usher. The ordered non-covalent 
polymerization of subunits occurs at the usher which recruits chaperone–subunit complexes, 
releases fimbrial subunits from the chaperones, and adds the subunits to the base of the 
growing fimbria. The usher protein forms a translocation pore in the outer membrane and 
transports the growing fimbria to the cell surface (Kline et al., 2010; Waksman & Hultgren, 
2009). Several small-molecule compounds, termed pilicides, have been identified to prevent 
CU fimbriae biogenesis process and therefore have potential therapeutic value by blocking 
adhesive organelles important in colonization. The designed compounds belong to a family 
of bicyclic 2-pyridones and interfere with the targeting of chaperone–subunit complexes to 
the usher by binding to the chaperone (Pinkner et al., 2006; Svensson et al., 2001; Åberg & 
Almqvist, 2007). Similarly, bicyclic 2-pyridones were shown to inhibit extracellular 
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nucleation/precipitation assembly pathway of adhesive amyloid fimbriae termed curli 
(Cegelski et al., 2009). 
1.2.2 Fimbriae as adhesins 
Fimbriae are generally described as adhesive organelles that mediate bacterial attachment 
and subsequent colonization, pathogen–host interactions, and tropism determination 
addressing bacteria to a specific site of infection (Table 1). The most studied fimbriae, type 1 
fimbria and P fimbria (pyelonephritis-associated fimbria), are composed of a rigid rod and a 
fibrillar tip (Jones et al., 1995; Kuehn et al., 1992; Lindberg et al., 1987). Type 1 fimbriae 
are expressed on the surfaces of most E. coli isolates  as  well  as  on  most  members  of  the  
Enterobacteriaceae family, and they mediate binding to D-mannosylated glycolipids and 
glycoproteins such as uroplakins via the adhesin FimH, which is located at the tip of the 
fimbria and is also interspersed along the fimbrial filament (Baorto et al., 1997; Hung et al., 
2002; Klemm & Christiansen, 1987; Krogfelt et  al., 1990; Zhou et  al., 2001). The type 1 
fimbriae of E. coli are important for intestinal colonization and subsequent transmission of 
E. coli in the host population (Bloch et  al., 1992) as well as bacterial attachment to the 
bladder epithelium and persistent colonization of E. coli in the lower urinary tract (Connell 
et al., 1996; Hung et al., 2002; Wright et al., 2007; Zhou et al., 2001). Minor allelic 
variation of the FimH receptor-binding domain affects tissue tropism through changes in the 
mannose receptor specificity (Pouttu et al., 1999; Sokurenko et al., 1994; Sokurenko et al., 
1995; Sokurenko et  al., 1998; Weissman et al., 2007). Similarly, UPEC strains associated 
with acute pyelonephritis express several variants of the P fimbrial tip adhesin PapG, which 
differ in their receptor specificity to different Gal(α1-4)Galβ moieties present in the 
globoseries of membrane glycolipids on erythrocytes of the P blood group and on 
uroepithelial cells (Leffler & Svanborg-Edén, 1981; Lund et al., 1987; Strömberg et al., 
1990). Further, the two other minor proteins (PapE and PapF) at the tip structure mediate 
bacterial adherence to immobilized fibronectin and to basolateral aspects of renal tubuli 
(Westerlund et al., 1991), suggesting that P fimbriae are multifunctional adhesive 
complexes. Similar dual epithelial and extracellular matrix (ECM)-binding is shown by the 
Dr adhesin of E. coli which binds to the decay accelerating factor on epithelium and to the 
N-terminal 7S fragment of type IV collagen (Nowicki et al., 1988; Nowicki et  al., 1993; 
Nowicki et  al., 2001; Westerlund et  al., 1989b). Adhesiveness to ECM is of importance in 
bacterial colonization of damaged tissue sites and has been proposed to potentiate bacterial 
spread through tissue barriers, e.g. from the intestine into the circulation, to cause systemic 
infection (Westerlund & Korhonen, 1993). 
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Table 1. Functions of E. coli fimbriae and examples of representative fimbrial types. 
1. Adhesion on eukaryotic cells   
Fimbrial type Host cells Receptor specificity Reference 
type 1 
 
Various cell types, such as 
erythrocytes; bladder, kidney, and 
intestinal epithelial cells; 
macrophages; brain microvascular 












Baorto et al., 1997; 
Edén & Hansson, 1978; 
Gbarah et al., 1991; 
Hung et al., 2002; 
Isaacson et al., 1978; 
Parkkinen et al., 1988a; 
Salit & Gotschlich, 1977; 
Sauter et al., 1991; Teng 
et al., 2005; Virkola, 
1987; Zhou et al., 2001 
P 
 
erythrocytes; kidney, bladder, and 




GbO4, and GbO5 
 
Adlerberth et al., 1995; 
Hull et al., 1981; 
Korhonen et al., 1982; 
Korhonen et al., 1986; 
Kuehn et al., 1992; 
Melican et al., 2011; 
Strömberg et al., 1990 
S 
 
erythrocytes; kidney, intestinal and 






Adlerberth et al., 1995; 
Korhonen et al., 1984; 
Korhonen et al., 1986; 
Moch et al., 1987; 
Parkkinen et al., 1986; 
Parkkinen et al., 1988a; 
Parkkinen et al., 1988b 
curli 
 




Ben Nasr et al., 1996; 
Kikuchi et al., 2005; 
Wang et al., 2006 
Dr erythrocytes; bladder, and intestinal 










Berger et al., 2004; 
Guignot et al., 2000; 
Korotkova et al., 2007; 
Nowicki et al., 1988; 
Nowicki et al., 1993; 
Nowicki et al., 2001;  
Van Loy et al., 2002 
F1845 erythrocytes, intestinal epithelial 
cells 
DAF, CEACAMs Berger et al., 2004; 
Guignot et al., 2000; 
Van Loy et al., 2002 




Anantha et al., 2004; 
Bühler et al., 1991; 
Jansson et al., 2006; 
Pieroni et al., 1988 
Mat/ECP 
 
larynx, cervical, and intestinal 
epithelial cells 
- Avelino et al., 2010; 
Lasaro et al., 2009; 
Rendón et al., 2007; 
Saldaña et al., 2009 
2. Invasion into eukaryotic cells   
Fimbrial type Host cells  Reference 
type 1 bladder and kidney epithelial cells; brain microvascular 
endothelial cells 
 Li et al., 2009;  
Martinez et al., 2000; 
Teng et al., 2005 
curli  cervical, bladder, and larynx epithelial cells   Gophna et al., 2001; 
Gophna et al., 2002; 
Uhlich et al., 2009; 
Wang et al., 2006 
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Dr  cervical and ovary epithelial cells  Das et al., 2005; 
Goluszko et al., 1997 
HCP  intestinal epithelial cells  Xicohtencatl-Cortes et 
al., 2009 
3. Binding to ECM proteins   
Fimbrial type Receptors  Reference 
type 1 fibronectin, laminin, type I and type IV collagens   Kukkonen et al., 1993; 
Pouttu et al., 1999; 
Sokurenko et al., 1994 
P fibronectin  Westerlund et al., 
1989a; Westerlund et 
al., 1991 
S  fibronectin, laminin  Sarén et al., 1999; 
Virkola et al., 1993 
curli fibronectin, laminin  Gophna et al., 2002; 
Olsén et al., 1989; 
Olsén et al., 1993 
Dr type IV collagen   Korotkova et al., 2007; 
Selvarangan et al., 
2004; Westerlund et al., 
1989b 
G laminin  Saarela et al., 1996 
LPF fibronectin, laminin, type IV collagen   Farfan et al., 2011 
HCP  fibronectin, laminin   Xicohtencatl-Cortes et 
al., 2009 
4. Biofilm formation   
Fimbrial type Target  Reference 
Type 1 polyvinyl chloride (PVC), polystyrene; intestinal and 
bladder epithelial cells 
 Bollinger et al., 2006; 
Hancock et al., 2011; 
Orndorff et al., 2004; 
Pratt & Kolter, 1998; 
Wright et al., 2007 
curli polystyrene, polyurethane, Thermanox™ plastic, 
stainless steel, glass, Teflon 
 Kikuchi et al., 2005; 
Prigent-Combaret et al., 
2000; Uhlich et al., 
2009; Vidal et al., 1998 
F1C polystyrene, glass  Hancock et al., 2011; 
Lasaro et al., 2009; 
Xicohtencatl-Cortes et 
al., 2009 
HCP glass  Xicohtencatl-Cortes et 
al., 2009 
AAF/II polystyrene, glass  Sheikh et al., 2001 
5. Protection against antimicrobials   
Fimbrial type Target  Reference 
curli peptide LL-37  Kai-Larsen et al., 2010 
longus lysozyme and several antibiotics  Clavijo et al., 2010 
6. Plasminogen activation by acting as a plasminogen receptor   
Fimbrial type   Reference 
type 1   Parkkinen & Korhonen, 
1989 
P   Parkkinen & Korhonen, 
1989 
S   Parkkinen et al., 1991 
curli   Sjöbring et al., 1994 
G   Kukkonen et al., 1998 
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7. Twitching motility   
Fimbrial type   Reference 
longus   Mazariego-Espinosa et 
al., 2010 




The adhesins of both type 1 and P fimbriae are of the catch-bond type in which the receptor-
ligand interaction is enhanced by mechanical force pulling the ligand and its receptor apart 
(Le Trong et  al., 2010; Nilsson et al., 2006; Thomas et al., 2002; Thomas et al., 2004). 
Although the helical filaments of type 1 and P fimbriae share structural similarities (Hahn et 
al., 2002), the characterization of their intrinsic biomechanical properties have uncovered 
differences, e.g. type 1 fimbria was shown to be more rigid and responds faster to an external 
force. It has been suggested that the dissimilarities have evolved to optimize functions of the 
fimbriae to the environmental conditions in different parts of the urinary tract; type 1-
fimbriated bacterial cells attached to epithelial cells in the urethra can resists high forces for 
a shorter time during the irregular urine flow, while UPEC ascending to kidney utilizes P 
fimbriae for adhesion in the upper urinary tract where a more constant urine flow is present 
(Andersson et al., 2006; Andersson et al., 2007). 
 
Fimbriae also participate in other functions than host cell adhesion, such as biofilm 
formation, invasion, plasminogen activation, and twitching motility (Table 1; Kline et  al., 
2010; Proft & Baker, 2009). For example, several types of fimbriae can immobilize a 
circulating host protease precursor plasminogen on the bacterial surface and thus enhance 
conversion of plasminogen into active plasmin by mammalian plasminogen activators. 
Adherence to ECM and creation of bacterial surface proteolysis with the aid of fimbrial 
structures can enhance bacterial invasion through tissue barriers and thus promote bacterial 
migration in the body (Lähteenmäki et al., 2001). 
1.2.3 Fimbriae as biofilm-promoting factors 
Biofilms are social consortia of cells that are surface-bound or localized to an air–liquid 
interface and encased in a self-produced extracellular matrix composed of highly hydrated 
exopolysaccharides, proteins, nucleic acids, and lipids (Flemming & Wingender, 2010). This 
communal lifestyle is an integral growth mode for most bacterial species; it allows bacteria 
to survive in stressful conditions and promotes transmission to new niches. Residence in a 
biofilm offers many advantages that are not equally enjoyed by planktonic bacteria, for 
example, improved acquisition of nutrients and transmissible genetic elements, and enhanced 
protection against antimicrobial agents, host-defence mechanisms, protozoan grazers, 
desiccation, hydrodynamic shear forces, ultraviolet radiation, and other environmental 
assaults (Hall-Stoodley et al., 2004; Karatan & Watnick, 2009). Biofilm formation occurs on 
virtually any surface exposed to bacterial populations; notably it was discovered that UPEC 
can form biofilm-like communities even in intracellular niche within the bladder superficial 
umbrella cells (Anderson et al., 2003) via a process dependent on type 1 fimbriae (Wright et 




Transition from single planktonic cells to complex three-dimensional biofilm structures 
occurs through several stages (Fig. 1). This complex process can be viewed as a 
developmental system (Monds & O'Toole, 2009; O'Toole et al., 2000; Stoodley et al., 2002). 
The first stage in biofilm formation, a reversible and initial attachment onto a surface, often 
involves flagella-mediated motility that permits the E. coli bacteria to overcome the 
repulsive forces generated between the two surfaces (Pratt & Kolter, 1998; Wood et al., 
2006). The irreversible attachment of cells to the surface necessitates the production of other 
surface structures, including type 1 fimbriae and curli, to strengthen the adhesion (Ghigo, 
2001; Pratt & Kolter, 1998; Reisner et  al., 2003; Vidal et al., 1998). An efficient adhesin, 
such as curli, F conjugative pilus or aggregative adherence fimbriae (AAF), can bypass the 
need for flagellar motility in the early stages of E. coli biofilm development (Prigent-
Combaret et al., 2000; Reisner et al., 2003; Sheikh et al., 2001). Next, cell division leads to 
building of microcolonies, and self-produced extracellular polymeric substances such as 
colanic  acid  immobilize  biofilm  cells  to  the  surface  and  to  each  other.  As  biofilm  
development proceeds, bacteria undergo profound physiological and metabolic adjustments, 
including induction or downregulation of fimbriae genes (Domka et al., 2007; Hancock & 
Klemm, 2007; Schembri et al., 2003). Thus, biofilm cells display different phenotypes 
relative to planktonic cells (Stewart & Franklin, 2008). Integration of a variety of 
environmental, cell-to-cell, and intracellular signals into an ordered interplay of regulatory 
networks determines the architecture of mature biofilms, such as mushroom- or tower-like 
structures (Karatan & Watnick, 2009; Prüß et al., 2006). Finally, seeding and spread of new 
biofilms is initiated through detachment of cells and erosion of the mature biofilm as well as 
by programmed generation and release of differentiated, highly motile cells known as 
dispersal cells (McDougald et al., 2012). 
 
 
Figure 1. Developmental model of biofilm formation. Biofilm formation starts with the reversible 
attachment (I) of flagellated bacteria to a surface and proceeds to irreversible attachment (II) via lost 
of motility and production of specific adhesins such as fimbriae. After stable association with the 
surface, bacteria form microcolonies and produce an extracellular matrix that holds the cells together 
(III). Biofilm formation progress to maturation (IV) with characteristic three-dimensional architecture, 
in some cases pillars with water channels. At the dispersion stage (V), a subpopulation of cells will 
undergo lysis, and another subpopulation of differentiated, motile cells disperses from the biofilm. 
Modified from Stoodley et al. (2002). 
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1.3 Genetic organization and regulation of fimbriae in E. coli 
1.3.1 Fimbrial operons and gene variation 
With the availability of complete genome sequences for various E. coli isolates, it has 
become clear that each E. coli chromosome harbors large number (≥10), and mainly unique 
repertoire, of fimbrial operons (Archer et al., 2011; Chaudhuri et al., 2010; Low et al., 2006; 
Vejborg et al., 2011). For example, the K-12 strain MG1655 harbours 11 operons that 
belong to chaperone–usher family (Korea et al., 2010). In addition, several E. coli plasmids 
contain gene clusters for fimbriae expression (Czeczulin et al., 1997; Evans et al., 1975; 
Shipley et al., 1978; Stone et  al., 1996). Such diversity in fimbrial systems enables a 
bacterium to express several types of fimbrial functions and consequently bind to different 
receptors on different hosts and on different sites within the same host. The apparent 
functional redundancy also promotes immune evasion. The expression of fimbrial operons 
are known to be interconnected to limit coexpression of similar fimbrial operons and to 
prevent excessive immune stimulation, as well as to achieve sequential expression of 
fimbriae (Holden & Gally, 2004; Totsika et al., 2008). Thus, a single bacterium seldom 
produces various types of fimbriae simultaneously. 
 
Fimbrial operons share common genetic organization within a certain fimbrial assembly 
pathway. For example, the chaperone-usher fimbrial operon typically contains genes 
encoding a major subunit, a chaperone, an usher, a minor subunit, and a tip adhesin. One or 
two genes encoding fimbriae regulatory proteins are located upstream of the operon (Korea 
et al., 2011; Nuccio & Bäumler, 2007). In some cases, additional regulatory genes are 
located downstream of the main fimbrial operon (Sjöström et al., 2009a; Sjöström et al., 
2009b). Fimbrial genes display significant sequence divergence, particularly the fimbrial 
adhesins and the regions of major structural subunit that are predicted to encode surface 
exposed epitopes (Bauchart et al., 2010; Boyd & Hartl, 1998; Peek et al., 2001; Weissman et 
al., 2006). As in the case of the variation of the repertoire of fimbrial gene clustres among E. 
coli isolates, the allelic variation increases avoidance of the host immune defense systems 
and contributes to differences in the receptor-binding specificity. The FimH diversification 
represents a well-characterized example of pathoadaptation; certain FimH variants in UPEC 
strains enhance mannose-sensitive binding to host glycoproteins and/or colonization of the 
urinary tract (Sokurenko et  al., 1998; Weissman et al., 2007), while a naturally occurring 
A62S substitution associated within NMEC strains enables E. coli to  adhere  to  collagens  
(Pouttu et al., 1999). 
1.3.2 Regulators controlling fimbriae expression 
The regulation of bacterial transcription has been viewed as a rather simple process 
compared to that in eukaryotes. However, until recently, the technological breakthroughs, 
high-throughput analyses, and increased sequencing capacity has re-shaped our 
understanding of the bacterial transcriptome in terms of complexity and versatility. Processes 
that alter the rates of transcriptional elongation and termination, mRNA degradation, and 
mRNA translation are no longer seen as curiosities (Belasco, 2010; Serganov & Patel, 2007; 
Sorek & Cossart, 2010). In bacteria, transcription initiation is a prominent regulated step in 
gene expression. The E. coli K-12 genome contains more than 2400 experimentally 
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determined transcriptional start sites and over 1200 predicted promoters (Mendoza-Vargas et 
al., 2009). About 270 species of DNA-binding transcription factors, 20-30 species of RNA 
polymerase-binding regulatory proteins, and seven species of promoter recognition sigma 
factors modulate the promoter selectivity of RNA polymerase (Ishihama, 2010). Moreover, a 
wide variety of post-transcriptional and translational regulatory mechanisms including 
numerous RNA regulators ensures appropriate protein synthesis (Storz et al., 2011; Waters 
& Storz, 2009). 
 
The complex interactions between gene repertoire and the regulatory apparatus form 
multilayered, hierarchical regulatory networks that constantly modulate the cell responses 
according to the environmental conditions. Two-component signal transduction (TCST) is 
the predominant bacterial system for sensing environmental factors and transmission of the 
information to cell interior, and TCST typically is composed of a membrane-associated 
histidine sensor kinase and a cytoplasmic response regulator (Gao & Stock, 2009). Over 
10% of transcription factors in E. coli are involved in TCST systems (Oshima et al., 2002; 
Yamamoto et  al., 2005). A specific environmental input signal is perceived by the sensor 
kinase, which auto-phosphorylates at its transmitter domain and donates the phosphate to the 
receiver domain of a response regulator, thereby modulating its activity. For instance, cell-
surface and cell-cell interactions trigger alterations in the integrity of the bacterial surface, 
such as membrane perturbations. The alterations of the bacterial envelope are sensed by at 
least six envelope stress response pathways in E. coli (Bury-Moné et al., 2009; McBroom & 
Kuehn, 2007; Rowley et al., 2006), including Cpx and Bae two-component systems and Rcs 
phosphorelay system. The latter system is an expanded form of the canonical TCST that 
involves additional phosphotransfer protein between sensor kinase and response regulator 
(Clarke, 2010). The Rcs phosphorelay plays a central role in the transition from a motile to a 
sessile biofilm lifestyle (Huang et  al., 2006; Majdalani & Gottesman, 2005) ensuring the 
timely production of biofilm-related factors, such as flagellum, curli, and type 1 fimbria 
(Ferrières & Clarke, 2003; Francez-Charlot et al., 2003; Schwan et al., 2007; Vianney et al., 
2005). 
 
The assembly of hundreds of fimbriae on cell surface represents a considerable energy sink 
for the bacterial cell, and may stimulate host innate inflammatory responses during infection. 
Therefore, E. coli have developed a spectrum of sophisticated and finely controlled pathways 
to modulate fimbriation status (Clegg et  al., 2011). Rapidly sensing, interconnected 
regulatory networks control fimbriae gene expression in response to varying environmental 
conditions, such as shifts in temperature, pH, osmolarity, and nutrient levels. E. coli uses a 
combination of environmental signals to recognize the microenvironment and to optimize 
fimbriation in a proper niche at the correct time. Indeed, many of the identified E. coli 
fimbrial operons are poorly expressed under standard laboratory growth conditions (Korea et 
al., 2010; Low et al., 2006). Generally, the expression is optimal at a temperature of 37°C, 
the internal temperature of mammalian hosts. For instance, type 1 fimbria (Gally et al., 
1993), P fimbria (Göransson & Uhlin, 1984), and S fimbria (Schmoll et al., 1990) have a 
maximal expression level at 37°C while curli is efficiently transcribed in vitro at lower 
temperatures (Olsén et al., 1989). The production of fimbriae is also dependent on the 
bacterial growth rate: the assembly of type 1 fimbriae into surface organelles occurs at early 
logarithmic phase and decreases dramatically as the culture enter the late logarithmic phase 
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(Dodd & Eisenstein, 1984), whereas curli genes are maximally expressed during stationary 
phase (Olsén et al., 1993). 
 
Fimbriae promoters are recognized to be under the control of multiple transcription factors. 
The factors mediating transcriptional regulation of fimbriae expression are either global 
regulators  controlling  the  expression  of  a  variety  of  genes  throughout  the  genome or  more  
restricted local regulators encoded by the respective fimbrial operons. The highly expressed 
histone-like nucleoid structuring protein H-NS is involved in global modulation of gene 
expression and DNA condensation and preferentially interacts with intrinsically curved 
DNA, which is commonly found at promoters (Atlung & Ingmer, 1997; Dorman, 2004). H-
NS has a central role in the adaptability of cells to changing environmental conditions 
(Hommais et al., 2001), and it mediates temperature regulation as a repressor in many 
fimbrial operons, such as the type 1 fimbria (Kawula & Orndorff, 1991), P fimbria 
(Göransson et  al., 1990), S fimbria (Morschhäuser et al., 1993), and curli (Olsén et al., 
1993). The relief of H-NS-mediated repression can be achieved by various mechanisms 
(Stoebel et al., 2008). Most commonly, promoter-specific transcriptional activators act as an 
antagonist that compete with H-NS for binding to promoter or displace H-NS-nucleoprotein 
complex from the promoter. For example, expression of the two adjacent divergently 
transcribed curli operons csgBA and csgDEFG are repressed by H-NS, and the curli activator 
CsgD is required for activation of H-NS-silenced curli genes (Hammar et  al., 1995). The 
transcription of csgD is  under  the  control  of  two  sigma  factors  and  more  than  10  
transcription factors, and thus the csgD promoter represent one of the most complex 
promoters in E. coli (Ishihama, 2010; Ogasawara et al., 2011).  
 
A  cAMP  receptor  protein  CRP  is  another  global  regulator  involved  in  gene  expression  of  
multiple chaperone-usher fimbrial operons (Båga et al., 1985; Edwards & Schifferli, 1997; 
Korea et al., 2010; Müller et al., 2009; Weyand et al., 2001). The CRP protein is activated 
by the binding of a signal metabolite 3′,5′-cyclic adenosine monophosphate (cAMP; Kim et 
al., 1992; Passner & Steitz, 1997) in response to several environmental conditions such as 
glucose starvation (Ishizuka et  al., 1993). CRP-cAMP directly controls the expression of 
several hundreds genes including operons needed for carbon source catabolism of non-
glucose sugars (Gosset et al., 2004; Grainger et al., 2005; Shimada et al., 2011; Zheng et al., 
2004). In contrast to H-NS, CRP-cAMP can both repress and activate fimbriae expression. 
For  example,  the  expression  of  type  1  fimbriae  is  repressed  by  CRP-cAMP (Müller et al., 
2009) while the opposite action is seen for P fimbriae expression (Weyand et al., 2001). 
1.3.3 Phase variation 
Heterogeneity in surface antigens is a key feature in adaptation of E. coli to different niches. 
In addition to differences in adhesin clusters present in E. coli genomes leading to 
interpopulation diversity, the species can also exhibit cell-to-cell phenotypic variability 
within a genetically clonal population. Phase variation is an important adaptive strategy to 
reversibly switch on and off the expression, creating variant subpopulations. Two general 
processes that give rise to fimbrial phase variation are targeted genetic rearrangement and 
epigenetic control. Type 1 fimbriae expression is a well-studied example of ON/OFF phase 
variation due to high-frequency site-specific recombination at specific loci. The orientation 
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of the invertible DNA element known as the fim switch (fimS), which is flanked by two 9-bp 
inverted repeat sequences and contains the promoter for fim structural gene expression, 
determines when the transcription of the fim operon occurs (Abraham et al., 1985; Freitag et 
al., 1985). The precise inversion is catalyzed by the fimbria-specific recombinases FimB and 
FimE that use the inverted repeats as a substrate (Gally et al., 1996; Klemm, 1986; McClain 
et al., 1991). The adjustment of the balance between the two fimbriation states responds to 
environmental signals (Gally et al., 1993; Schwan et al., 2002), and several regulators, such 
as H-NS, Lrp, IHF, CRP-cAMP, and RcsB, are known to affect  the recombination process 
by directly interacting with the fimS and/or modulating the expression of the recombinases 
(Blomfield et  al., 1993; Corcoran & Dorman, 2009; Eisenstein et al., 1987; Gally et al., 
1994; Kawula & Orndorff, 1991; Schwan et al., 2007). In addition, sequence polymorphism 
within and adjacent to the fimS results in variation in the switching behaviour among UPEC 
isolates (Leathart & Gally, 1998). 
 
Phase variation in the expression of P, S, F1651, F1652, F1845, CS31A, and K88 fimbriae 
does not involve rearrangements in DNA sequences (Blyn et al., 1990; Daigle et al., 2000; 
Huisman & de Graaf, 1995; Martin, 1996; van der Woude & Low, 1994). Their cell-to-cell 
variation has an epigenetic basis; the expression is dependent on reversible changes in Dam 
methylation status of GATC sites located in the promoter region. The mechanism involves 
deoxyadenine methylase (Dam) and leucine-responsive regulatory protein (Lrp) that 
compete for access to GATC sites. The resulting changes in methylation in turn alter the 
binding of transcription factors to the promoter and hence control the initiation of 
transcription (for review, see Casadesús & Low, 2006). 
1.3.4 Post-transcriptional regulation 
Post-transcriptional regulation of RNA is a common and efficient strategy for controlling 
gene expression. Contrary to the general view, it is not a characteristic restricted to 
eukaryotic mRNA but also plays an important and often underestimated means of 
modulating bacterial gene expression. mRNA stability is a tightly regulated and integral part 
of gene expression. Another level of post-transcriptional control takes place during 
translation; initiation of translation is rate-limiting for protein synthesis and is the main 
target for translational control. For instance, the expression of the curli regulator CsgD is 
post-transcriptionally controlled by two antisense small RNAs, OmrA and OmrB, that affect 
translational efficiency by interacting with the csgD 5′-UTR (Holmqvist et al., 2010). trans-
acting ribonucleases (RNases), RNA binding proteins, and small RNAs continuously 
intervene mRNA turnover and maturation to adjust mRNA concentrations and to ensure 
fidelity of the synthesized transcripts (Arraiano et  al., 2010; Storz et al., 2011). RNA 
degradation is also needed to recycle ribonucleotides for incorporation into new RNA 
molecules. RNase E is a principal endoribonuclease in E. coli and acts as a scaffold for a 
RNA degradosome, a large multiprotein complex involved in degradation of bulk RNA 
(Carpousis, 2007; Py et al., 1994). In addition, RNase E participates in the processing and 
maturation  of  a  variety  of  RNA  molecules  by  cleaving  its  substrates  in  A+U-rich  regions  
(Callaghan et al., 2005; McDowall et al., 1994). Fimbrial genes encoding the structural 
components are generally clustered into transcriptional unit and co-transcribed from a single 
promoter. The polycistronic operon structure ensures coordination of expression as all 
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proteins needed for the biogenesis are synthesized concurrently. However, the fimbrial 
proteins are required in nonstoichiometric amounts; the need for the major fimbrillin is much 
larger than for the minor subunits and assembly proteins. mRNA processing iniated by 
endoribonucleolytic cleavage is important mechanism to selectively degrade discrete 
segments  of  polycistronic  transcripts  and  to  yield  transcripts  of  different  stability,  thereby  
achieving differential expression of multiple translational units in polycistronic mRNAs. 
Such posttranscriptional regulatory process is known to occur in the expression of P- 
(Bricker & Belasco, 1999; Båga et al., 1988; Nilsson & Uhlin, 1991; Nilsson et al., 1996), S- 
(Balsalobre et al., 2003), CFA/I- (Jordi et al., 1993), and F1845-fimbriae (Bilge et al., 1993; 
Koo et al., 2004). In the case of P and S fimbriae expression, the processing involves RNase 
E-dependent endoribonucleolytic cleavages to achieve a stable transcript encoding the major 
structural subunit while endoribonucleolytic cleavage of polycistronic mRNA in the operon 
encoding F1845 fimbriae is independent of RNase E but requires HrpA, a RNA helicase 
from the DEAH-box family.  
 
Partial termination of transcription also regulates the relative production of the fimbriae 
proteins (Balsalobre et al., 2003; Båga et al., 1985; Hammar et al., 1995; Jordi et al., 1993). 
The termination site directly downstream from the major subunit genes dictates whether or 
not transcription of the downstream genes will occur. An intrinsic, Rho-independent 
transcriptional terminator has a GC-rich palindromic stem with tetraloop followed by a short 
uracil-rich stretch of sequence (d'Aubenton Carafa et al., 1990). The termination occurs at or 
near the U-stretch which form a particularly unstable RNA-DNA hybrid (Martin & Tinoco, 
1980), thereby causing pausing of the transcription complex, folding of the terminator 
hairpin, and finally dissociation of the transcription complex and release of the nascent RNA 
transcript (Gusarov & Nudler, 1999; Wilson & von Hippel, 1995). Also binding of the 
regulatory protein Rho to untranslated nascent transcript destabilizes the RNA-DNA hybrid 
and dissociates the mRNA from RNA polymerase (Richardson et al., 1975; Roberts, 1969). 
The phase-variable termination of the type 1 fimbriae fimE mRNA has been demonstrated to 
be post-transcriptionally controlled by a Rho-dependent terminator located in the fimS switch 
that terminates transcription when fimS is in the OFF orientation (Hinde et al., 2005; Joyce 
& Dorman, 2002). Moreover, translational control, e.g. through different ribosomal binding 
sites in polycistronic mRNA, contributes to the proper stoichiometric expression of different 
genes in polycistronic operons (Deana & Belasco, 2005). 
1.3.5 Cross-talk between different fimbrial operons 
Multiple studies utilizing mainly UPEC strains have demonstrated that regulatory cross-talk 
exists between different fimbrial gene clusters (Holden et al., 2001; Holden et al., 2006; 
Lindberg et al., 2008; Sjöström et al., 2009a; Snyder et al., 2005; Totsika et al., 2008; Xia et 
al., 2000). Although E. coli isolates  commonly  have  the  potential  to  express  an  array  of  
fimbrial structures, they seldom produce more than one type of fimbria simultaneously on 
the bacterial surface (Nowicki et al., 1984; Xia et al., 2000). This indicates the precence of 
regulatory mechanisms that prevent fimbrial coexpression and could promote sequential 
expression at the single-cell level (reviewed by Holden & Gally, 2004). There can be many 
copies of pap operons encoding P fimbriae within the same chromosome of UPEC isolate. 
Totsika and co-workers (2008) found that sequence variation in the pap regulatory regions as 
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well as in the P fimbriae regulators PapI and PapB prevent cross-activation of these 
homologous fimbrial operons. Xia et al. (2000) showed that introduction of PapB into E. coli 
K-12 induces on-to-off phase transition frequency of the type 1 fimbriae by blocking FimB 
recombinase activity at the fimS switch and increasing FimE expression. Further studies 
demonstrated that some PapB paralogues, namely SfaB (S fimbriae), FocB (F1C fimbriae), 
and  PefB  (Salmonella enterica serovar Typhimurium –plasmid-encoded fimbriae), also 
affect the expression of type 1 fimbriae in an inverse manner (Holden et al., 2001; Lindberg 
et al., 2008). The distal end of the main sfaII fimbrial operon of the NMEC strain IHE 3034 
contains the sfaXII locus (Sjöström et al., 2009b). The ectopic overexpression of SfaXII 
down-regulates type 1 fimbriae expression by altering the phase variation control and 
transcriptional activity from the fimA promoter (Sjöström et al., 2009a). Regulation also 
occurs in the opposite direction; the expression of type 1 fimbriae repress P fimbria 
expression (Snyder et al., 2005), and PapB has the ability to repress the expression of F1C 
fimbriae (Lindberg et  al.,  2008).  Moreover,  FocB  was  shown  to  activate  P  fimbria  
expression (Lindberg et al., 2008), representing an example of positive cross-talk between 
related gene clusters. 
1.3.6 Stick or swim: cross-talk between fimbrial operons and flagella system 
E. coli is  generally  motile,  and  expression  of  flagella  has  been  shown  to  contribute  to  
pathogenicity of E. coli (Lane et  al., 2005; Lane et al., 2007b; Wright et  al., 2005). In 
addition to motility, flagella filaments of E. coli mediate adherence to host cells and mucus 
(Erdem et al., 2007; Girón et al., 2002; Mahajan et al., 2009; Parthasarathy et al., 2007; Roy 
et al., 2009), promote host cell invasion (Luck et al., 2006; Parthasarathy et al., 2007; 
Pichon et al., 2009), and contribute to biofilm formation (Pratt & Kolter, 1998; Wood et al., 
2006). The biosynthesis and operation of the large flagella organelles necessitate 
considerable investments of energy and resources. Over 60 genes are required for the process 
of assembly and function of the flagellum (Brown et al., 2009). In addition, flagellation may 
provoke innate immune system during infection (Hayashi et  al.,  2001).  Hence,  tight  and  
precise regulation of flagella regulon in response to environmental changes is necessary. As 
a result, the flagella genes are under a complex regulatory cascade of three classes and their 
expression is controlled in a hierarchical manner to facilitate ordered secretion and assembly 
process (Kalir et  al., 2001; Soutourina & Bertin, 2003). The heteromultimeric master 
regulator FlhD4C2 is situated at the top of the hierarchy and dictates when flagella are 
produced (Komeda, 1986; Kutsukake et al., 1990; Liu & Matsumura, 1994). Expression of 
flhDC operon is the main regulatory point of flagella system. The flhDC promoter  is  
controlled by many environmental factors and several regulators including H-NS (Bertin et 
al., 1994; Soutourina et al., 1999), CRP-cAMP (Silverman & Simon, 1974; Soutourina et 
al., 1999), OmpR (Shin & Park, 1995), and the response regulator RcsB with its accessory 
cofactor RcsA (Francez-Charlot et al., 2003). After the initiation of flhDC transcription, the 
stability of formed message is regulated by the small RNA-binding protein CsrA (Wei et al., 
2001). FlhD4C2 is further controlled at the level of protein stability by the protease ClpXP 
(Tomoyasu et al., 2003). 
 
To avoid simultaneous expression of attachment-promoting fimbriae and motility-enhancing 
flagella, bacteria have evolved mechanisms for reciprocal regulation of these traits (Akerley 
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et al., 1995; Clegg & Hughes, 2002; Gardel & Mekalanos, 1996; Holden & Gally, 2004; Li 
et al., 2001; Ogasawara et al., 2011; Pesavento et al., 2008; Saini et al., 2010; Simm et al., 
2004). Indeed, the production of flagella in E. coli is decreased after transition from a 
planktonic to an adhesive lifestyle (Cleary et al., 2004; Prigent-Combaret et al., 1999). Lane 
et al. (2007a) demonstrated that abundance of type 1 fimbrial structures at the cell surface 
decreases motility of UPEC. Moreover, overexpression of P fimbriae protein PapX in UPEC 
or S fimbriae protein SfaXII in NMEC had a repressing effect on motility (Simms & Mobley, 
2008; Sjöström et al., 2009a). Similarly, motility of the uropathogen Proteus mirabilis was 
affected upon elevated expression of mrpJ, the last gene of the mrp operon encoding for the 
Proteus-like MR/P fimbriae (Li et  al., 2001; Pearson & Mobley, 2008). It has been shown 
that both PapX and MrpJ directly bind to the flhDC flagellar master operon, leading to a 
repression of transcription of the master regulator FlhD4C2 (Pearson & Mobley, 2008; Reiss 
& Mobley, 2011). SfaX has 96% amino acid identity with PapX (Sjöström et al., 2009b) and 
thus likely has affinity towards flhDC promoter; however, this has not yet been established. 
1.4 The common and conserved mat fimbrial operon 
Mat fimbria was discovered in Timo Korhonen’s laboratory during studies on the S- and 
type 1-fimbria-negative derivative of NMEC isolate IHE 3034. The expression of the Mat 
fimbria in vitro was found to be restricted to the genetically conserved 18ac:K1:H7 clonal 
group of NMEC strains cultivated at a low temperature (20°C); hence the peritrichous 
filament structures were named meningitis associated  and  temperature regulated (Mat) 
fimbriae. Characterization of the fimbria revealed that it has a diameter of 5 to 7 nm and a 
length varying between 0.4 to 5 µm, and the filament is composed of a 18 kDa fimbrillin 
protein encoded by matB gene  (Pouttu et  al., 2001; see Fig. 2). The filaments protruding 
from the bacterial surface has been observed to coil together (Fig. 2) forming 12-nm-wide 
structures that appear to tether bacterial cells to each other (Avelino et al., 2010; Garnett et 
al., 2012; Rendón et al., 2007). In addition to matB gene, matA and matC were shown to 
Figure 2. Production of Mat 
fimbriae in E. coli. Schematic 
presentation of the mat operon 
in the chromosome of E. coli 
IHE 3034, and the predicted 
function of the gene products 
according to Pouttu et al. 
(2001), Rendón et al. (2007), 
and Garnett et  al. (2012). The 
electron micrograph shows the 
negatively stained E. coli K-12 
strain HB101 (pMAT6) cell 
carrying the matBCDEF genes 
from IHE 3034 under the 
inducible ptrc promoter. 
Arrowheads point to 
representative intertwined Mat 
fimbriae. No fimbrial structures 
were seen in HB101 harbouring 
the pSE380 as a vector control. 
Size bar, 0.5 μm. 
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affect Mat fimbria biogenesis (Pouttu et al., 2001). These genes are a part of compact 7-kb 
gene cluster located on the chromosome of IHE 3034 (Fig. 2). Based on usher protein 
comparison, the Mat fimbria belongs to the alternate chaperone–usher family (α-fimbriae), a 
relatively small but highly divergent group of fimbriae (Nuccio & Bäumler, 2007). However, 
the whole 7-kb mat gene cluster region does not share significant homology with DNA 
encoding other fimbrial adhesins (Pouttu et al., 2001). Interestingly, the mat region is highly 
similar, 97.8 % identical in sequence, to the corresponding region in the MG1655 (K-12) 
chromosome; however, MG1655 is incapable of Mat fimbriae expression in standard growth 
medium (Pouttu et al., 2001). A considerable amount of evidence suggests that MatB 
fimbrillin represents a very common and highly conserved surface structure in E. coli; over 
91% of the E. coli isolates representing different pathovars as well as commensals harbor 
matB and nearly 60% express the fimbria (Table 2). Because of the wide distribution of the 
fimbrillin gene among the E. coli, Rendón and co-workers (2007) proposed an alternative 
name E. coli common pilus (ECP) for the fimbria.  
 
Table 2. Distribution of matB gene and surface expression of Mat fimbriae in human E. coli isolates. 
Pathogroupa Presence of matB Mat expression Reference 
Various (mainly NMEC and 
UPEC)  
25/27 (91.7%) 5/27 (18.5%)b Pouttu et al., 2001 
Various (mainly IPEC and 
NFEC) 
169/176 (96.0%) 121/169 (71.6%)c Rendón et al., 2007 
ETEC 109/136 (80.1%) 25/43 (58.1%)d Blackburn et al., 
2009 
EPEC 30/30 (100%) 19/30 (63.3%)e Saldaña et al., 2009 
atypical EPEC 29/29 (100%) Not determined Scaletsky et al., 2010 
atypical EPEC 61/71 (85.9%) 26/71 (36.6%)f Hernandes et al., 
2011 
EAEC 125 /130 (96.2%) 79/125 (63.2%)f Avelino et al., 2010 
UPEC 28 / 28 (100%) Not determined Narciso et al., 2011 
    
Total 576/627 (91.9%) 274/465 (59.1%)  
a EAEC, enteroaggregative E. coli; EPEC, enteropathogenic E. coli; ETEC, enterotoxigenic E. coli; 
IPEC, intestinal pathogenic E. coli; NFEC, normal flora E. coli; NMEC, neonatal meningitis E. coli; 
UPEC, uropathogenic E. coli. 
b Detected in cells cultivated at 20°C in Luria-Bertani (LB) by indirect immunofluorescence 
microscopy (IFM) and serum agglutination. 
c Detected in cells cultivated at 26°C in Dulbecco's Modified Eagle Medium (DMEM) by flow 
cytometry.  
d Detected in cells cultivated at 37°C under 5% CO2 in pleuropneumonia-like organism (PPLO) 
medium by Western blotting. 
e Detected in cells cultivated at 37°C in DMEM with cultured HT-29 colonic epithelial cells by flow 
cytometry and IFM. 
f Detected in cells cultivated at 37°C in DMEM with cultured HEp-2 larynx epithelial cells by IFM. 
 
 
Several studies support the idea that the Mat/ECP fimbria is an important colonization factor 
of E. coli. Various E. coli isolates from diverse origins are able to produce the fimbriae when 
adhering to cultured human epithelial cells (Avelino et  al., 2010; Blackburn et al., 2009; 
Hernandes et al., 2011; Rendón et al., 2007; Saldaña et al., 2009), and functional analysis of 
isogenic matB (ecpA) mutants have confirmed a role for Mat/ECP in host-cell adherence 
(Avelino et  al., 2010; Lasaro et  al., 2009; Rendón et al., 2007; Saldaña et al., 2009). 
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Recently, Garnett et al. (2012) showed that EcpD/MatE is preferentially located at the tip of 
the fimbrial stalk and performs the role of a tip-associated adhesin. Further, available data 
indicate that the Mat/ECP fimbria is expressed in vivo. Rendón et  al. (2007) were able to 
detect circulating antibodies against Mat/ECP in different pools of sera, collected from 
bovines, healthy humans, and patients suffering hemolytic uremic syndrome caused by 
EHEC. Lasaro and co-workers (2009) demonstrated that the fimbria is an essential 
colonization determinant for the probiotic E. coli strain Nissle 1917 in the intestine of infant 
mouse. However, the tissue receptor for Mat fimbriae remains to be identified. 
 
The regulation of Mat fimbriae is modulated by growth temperature and the composition of 
the culture medium, and the expression seems to differ among clonal groups of E. coli. 
While NMEC strains produced the fimbriae in LB broth at 20°C (Pouttu et al., 2001), 
growth in the eukaryotic-cell culture medium DMEM in the presence of 5% CO2 induced the 
Mat expression in IPEC both at 26°C and 37°C (Table 2). In contrast, cultivation in LB did 
not induce the production of Mat fimbriae in EHEC at 26°C and 37°C or EPEC at 37°C 
(Rendón et al., 2007; Saldaña et al., 2009). Numerous genome-wide mRNA analyses (Table 
3) and studies of protein-DNA interactions (Cho et al., 2008; Grainger et al., 2005; Oshima 
et al., 2006; Shimada et  al., 2011) indicate that mat expression is controlled by several 
global regulators, including H-NS, CRP-cAMP, and leucine-responsive protein Lrp. In 
addition, immunofluorescence microscopy analysis of NMEC by Pouttu et  al. (2001) 
suggests that expression of Mat fimbriae is regulated by phase variation. However, detailed 
information on the influence of regulatory systems on mat expression is not yet available. 
 
Table 3. mat genes in transcriptome analyses. 






hns mutation (Tn5seq1) FB8 (K-12) matBCD 1.7-8.3 Hommais 
et al., 2001 




MG1655Z1 (K-12) matA 3.8 Bury-Moné 
et al., 2009 
Acute acid stress (pH 3) 86-24 (EHEC 
O157 : H7) 
matBCDEF 4.1-28.8 House et 
al., 2009 
deletion of gadE Sakai (EHEC 
O157 : H7 
matB 1.3 Kailasan 
Vanaja et 
al., 2009 
20 mM butyrate vs 20 mM 
L-leucine 
Sakai (EHEC 
O157 : H7) 





2 Aims of the study 
At the time this thesis was initiated,  the Mat fimbria of E. coli had been  identified,  but  its  
functions and regulatory mechanisms were not characterized. The first publication 
characterizing the Mat fimbria (Pouttu et  al., 2001) described a particularly exciting 
observation: the major subunit gene was very common among E. coli isolates of diverse 
origin, in fact more common than the “common” type 1 fimbria, but the surface expression 
of the Mat fimbria under routine laboratory conditions was restricted to a highly virulent 
pathogroup of E. coli, i.e. the NMEC O18ac:K1:H7 isolates. Resolution of the molecular 
basis and evolutionary aspects of this differential expression and its possible adaptive 
advantages for NMEC formed the main motivation for my PhD study. During this thesis 
work, several studies (e.g. Lasaro et  al., 2009; Rendón et al., 2007; see Table 2) expanded 
the spectrum of Mat-expressing strains beyond the NMEC isolates. The studies provided 
information suggesting that Mat regulation may differ in E. coli pathovars and that the 
function(s) of Mat fimbria is(are) common, and hence probably important for E. coli as  a  
species.  
 
The specific aims of the present study were: 
1) to reveal a biological function(s) for the Mat fimbria; 
2) to characterize the mat operon genes; 
3) to detect environmental cues that promote the expression of Mat fimbriae; 
4) to  identify  components  of  the  regulatory  circuit(s)  controlling  the  expression  of  mat 
operon; and 
5) to resolve the molecular mechanisms behind the differential mat expression in NMEC and 




3 Materials and methods 
3.1 Bacterial strains and plasmids  
The strains and plasmids used in this study are listed in Table 4 and Table 5, respectively. 
 
Table 4. Bacterial strains used in this study. 
Bacterial strain  Description Article Source or reference 
Escherichia coli    
IHE 3034 clinical isolate, NMEC, O18:K1:H7, (also 
known as RK261) 
II Achtman et al., 1983; 
Korhonen et al., 1985 
IHE 3034-113 IHE 3034 rne131 - This study 
IHE 3034-Rif Rifampin-resistant IHE 3034 I-IV Pouttu et al., 2001 
IHE 3034-89 IHE 3034-Rif ∆matA (+1 to +591 bp from 
the GTG of matA) 
- This study 
IHE 3034-90  IHE 3034-Rif matB::cat I Pouttu et al., 2001 
IHE 3034-91 IHE 3034-Rif ∆matB (+61 to +528 bp from 
the ATG of matB) 
 Lehti et al., 2010 
IHE 3034-92 IHE 3034-Rif ∆matC (+61 to +609 bp from 
the ATG of matC) 
I This study 
IHE 3034-93 IHE 3034-Rif ∆matD (+61 to +2466 bp 
from the ATG of matD) 
I This study 
IHE 3034-94 IHE 3034-Rif ∆matE (+61 to +1584 bp 
from the ATG of matE) 
I This study 
IHE 3034-95 IHE 3034-Rif ∆matF (+151 to +696 bp 
from the ATG of matF) 
I This study 
IHE 3034-96 IHE 3034-Rif ∆matBCDEF (+61 bp from 
the ATG of matB to +753 bp from 




IHE 3034-97 IHE 3034-Rif ∆matBCDEF complemented 
with matBCDEF 
I This study 
IHE 3034-101 IHE 3034-Rif matA(G496C), resulting in 
the substitution MatA A166P 
II This study 
IHE 3034-102 IHE 3034-Rif matA(A536C), resulting in 




IHE 3034-103 IHE 3034-102 complemented with matA II This study 
IHE 3034-104 IHE 3034-Rif rrnB T14-lacZ II This study 
IHE 3034-105 IHE 3034-Rif rrnB T14-pmatA-lacZ [-608 
to +81 from the GTG of matA (pA)] 
II This study 
IHE 3034-107 IHE 3034-Rif rrnB T14-pmatA-lacZ [-608 
to +745 from the GTG of matA(A536C) 
(pAB)] 
II This study 
IHE 3034-108 IHE 3034-102 rrnB T14-pmatA-lacZ [-608 
to +81 from the GTG of matA(A536C) 
(pA)] 
II This study 
IHE 3034-110 IHE 3034-102 rrnB T14-pmatA-lacZ [-608 
to +745 from the GTG of matA(A536C) 
(pAB)] 
II This study 
IHE 3034-120 IHE 3034-Rif rrnB T14-prcsB-lacZ (-803 to 
+20 from the ATG of rcsB) 
III This study 
IHE 3034-121 IHE 3034-Rif rrnB T14-prcsD-lacZ (-259 to 
+16 from the ATG of rcsD) 
III This study 
IHE 3034-122 IHE 3034-102 rrnB T14-prcsB-lacZ (-803 
to +20 from the ATG of rcsB) 
III This study 
IHE 3034-123 IHE 3034-102 rrnB T14-prcsD-lacZ (-259 
to +16 from the ATG of rcsD) 
III This study 
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IHE 3034-130 IHE 3034-Rif rrnB T14-pflhD-lacZ (-942 to 
+22 from the ATG of flhD) 
IV This study 
IHE 3034-131 IHE 3034-Rif rrnB T14-pfliC-lacZ (-712 to 
+38 from the ATG of fliC) 
IV This study 
IHE 3034-132 IHE 3034-102 rrnB T14-pflhD-lacZ (-942 to 
+22 from the ATG of flhD) 
IV This study 
IHE 3034-133 IHE 3034-102 rrnB T14-pfliC-lacZ (-712 to 
+38 from the ATG of fliC) 
IV This study 
IHE 3034-S1 IHE 3034-Rif S1 promoter region (-167 to 
+10 from the GTG of matA) swapped from 
MG1655 
II This study 
IHE 3034-S2 IHE 3034-Rif S2 promoter region (-343 to 
-147 from the GTG of matA) swapped 
from MG1655 
II This study 
IHE 3034-S3 IHE 3034-Rif S3 promoter region (-443 to 
-323 from the GTG of matA) swapped 
from MG1655 
II This study 
IHE 3034-S4 IHE 3034-Rif S4 promoter region (-608 to 
-421 from the GTG of matA) swapped 
from MG1655 
II This study 
IHE 3034-S12 IHE 3034-Rif S12 promoter region (-343 
to +10 from the GTG of matA) swapped 
from MG1655 
II This study 
IHE 3034-S34 IHE 3034-Rif S34 promoter region (-608 
to -323 from the GTG of matA) swapped 
from MG1655 
II This study 
IHE 3034-150 IHE 3034-Rif ∆crp (+6 to +630 bp from the 
ATG of crp) 
- This study 
IHE 3034-Sm Streptomycin-resistant IHE 3034, 
O18:K1:H7 
I, II, III Pouttu et al., 1999 
IHE 3034-2 IHE 3034-Sm fimA::cat I Pouttu et al., 1999 
IHE 3034-8 IHE 3034-Sm sfaA::Gm I Pouttu et al., 1999 
IHE 3034-80 IHE 3034-Sm fliC::cat I Pouttu et al., 1999 
IHE 3034-59 IHE 3034-Sm fimA::cat sfaA::Gm   This study 
IHE 3034-79 
 
IHE 3034-Sm fimA::cat sfaA::Gm fliC::cat  I, IV Pouttu et al., 2001 
IHE 3034-99 IHE 3034-Sm fimA::cat sfaA::Gm fliC::cat 
∆matB 
I This study 
IHE 3034-200 IHE 3034-Sm hns::mini-Tn5cat II This study 
IHE 3034-201 IHE 3034-Sm hns::mini-Tn5cat 
matA(G496C), resulting in the substitution 
MatA A166P 
II This study 
IHE 3034-202 IHE 3034-Sm hns::mini-Tn5cat 
matA(A536C), resulting in the substitution 
MatA H179P 
II This study 
IHE 3034-203 IHE 3034-Sm rrnB T14-pmatA-lacZ [-608 
to +81 from the GTG of matA (pA)] 
II, III This study 
IHE 3034-204 IHE 3034-Sm rrnB T14-pmatA-lacZ [-608 
to +745 from the GTG of matA(A536C) 
(pAB)] 
II, III This study 
IHE 3034-205 IHE 3034-200 rrnB T14-pmatA-lacZ [-608 
to +81 from the GTG of matA (pA)] 
II This study 
IHE 3034-206 IHE 3034-200 rrnB T14-pmatA-lacZ [-608 
to +745 from the GTG of matA(A536C) 
(pAB)] 
II This study 
IHE 3034-207 IHE 3034-202 rrnB T14-pmatA-lacZ [-608 
to +81 from the GTG of matA (pA)] 
II This study 
IHE 3034-208 IHE 3034-202 rrnB T14-pmatA-lacZ [-608 
to +745 from the GTG of matA(A536C) 
(pAB)] 
II This study 
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IHE 3034-213 IHE 3034-Sm rcsB::mini-Tn5cat rrnB T14-
pmatA-lacZ [-608 to +81 from the GTG of 
matA (pA)] 
III This study 
IHE 3034-214 IHE 3034-Sm rcsB::mini-Tn5cat rrnB T14-
pmatA-lacZ [-608 to +745 from the GTG 
of matA(A536C) (pAB)] 
III This study 
IHE 3034-215 IHE 3034-Sm rrnB T14-pmatA-lacZ [-608 
to +745 with G-340T-337C-336A-331G-330C-327 
from the GTG of matA(A536C) (pABRcsAB 
box mut)] 
III This study 
IHE 3034-216 IHE 3034-204 ∆rcsC (+61 to +2790 bp 
from the TTG of rcsC) 
III This study 
IHE 3034-217 IHE 3034-204 ∆rcsD (+61 to +1834 bp 
from the ATG of rcsD] 
III This study 
IHE 3034-218 IHE 3034-204 ∆ackA ∆pta (+61 to +3362 
bp from the ATG of ackA) 
III This study 
MG1655  K-12, OR:H48 I, II Blattner et al., 1997 
MG1655-Rif Rifampin-resistant MG1655  II, IV This study 
MG1655-102  MG1655-Rif matA(A536C), resulting in 
the substitution H179P 
II, IV This study 
MG1655-S12  MG1655-Rif S12 promoter region (-343 to 
+10 from the GTG of matA) swapped from 
IHE 3034 
II This study 
MG1655-S123 MG1655-Rif S123 promoter region (-443 
to +10 from the GTG of matA) swapped 
from IHE 3034 
II This study 
MG1655-S1234 MG1655-Rif S1234 promoter region (-608 
to +10 from the GTG of matA) swapped 
from IHE 3034 
II This study 
AES29 MG1655 hns::cat II A. Sjöström and B.E. 
Uhlin, Umeå University, 
unpublished 
construction 
HB101 K-12 - American Type Culture 
Collection 
IHE 3040 clinical isolate, NMEC, O18:K1:H7  II Achtman et al., 1983; 
Korhonen et al., 1985 
IHE 3072 clinical isolate, NMEC, O2:K1:H5 II Achtman et al., 1983; 
Korhonen et al., 1985 
BEN79 APEC, O18:K1:H7 II Moulin-Schouleur et al., 
2007 
BEN374 APEC, O18:K1:H7 II Moulin-Schouleur et al., 
2007 
536 clinical isolate, UPEC, O6:K15:H31 II Berger et al., 1982 
CFT073 clinical isolate, UPEC, O6:K2:H1 II Mobley et al., 1990 
Nissle 1917 probiotic strain, DSM 6601, O6:K5:H1 II Grozdanov et al., 2004 
83972 clinical isolate, ABU, OR:K5:H– II Lindberg et al., 1975 
E2348/69 clinical isolate, EPEC, O127:H6 II Levine et al., 1978 
LF82 clinical isolate, AIEC, O83:H1 II Darfeuille-Michaud et 
al., 1998 
ABU 38 clinical isolate, ABU I, II Lindberg et al., 1975 
285 clinical isolate, NMEC, O78 II Ron et al., 1991 
789 APEC, O78 II Babai et al., 1997 
BL21(DE3) F- ompT dcm lon hsdSB (rB– mB– ) gal 
λDE3 
II, IV Studier & Moffatt, 1986 
BL21(AI) slyD F− ompT dcm hsdSB (rB−mB−) gal 
araB::T7RNAP-tetA ∆slyD::cat 
III Daniel et al., 2006 
S17-1 λpir recA thi pro hsdR RP4-2-Tc::Mu Km::Tn7 
SmR TpR λpir 
I-IV Simon et al., 1983 
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Sm10 λpir thi, thr, leu, tonA, lacY, supE, recA::RP4-
2-Tc::Mu KmR λpir 
II, III Simon et al., 1983 
Bifidobacterium longum   




Table 5. Plasmids used in this study. 
Plasmid Description Article Source or reference 
pSE380 Expression vector, ptrc, lacI, lacO, ApR I-IV Invitrogen 
pMAT19 IHE 3034 matA under ptrc in pSE380 II, III, IV This study 
pMAT10 IHE 3034 matB under ptrc in pSE380 I Pouttu et al., 2001 
pMAT12 IHE 3034 matC under ptrc in pSE380 I This study 
pMAT13 IHE 3034 matD under ptrc in pSE380 I This study 
pMAT14 IHE 3034 matE under ptrc in pSE380 I This study 
pMAT15 IHE 3034 matF under ptrc in pSE380 I This study 
pMAT6 IHE 3034 matBCDEF under ptrc in 
pSE380 
I, III, IV Pouttu et al., 2001 
pMAT20 MG1655 matBCDEF under ptrc in 
pSE380 
I This study 
pMAT21 MG1655 matA under ptrc in pSE380 II This study 
pRCSB1 IHE 3034 rcsB under ptrc in pSE380 III This study 
pRS551 Transcriptional lacZ fusion vector, ApR, 
KmR 
 Simons et al., 1987 
pRS551-∆trpt  pRS551 ∆trpt (+17 to +69 bp from the 
EcoRI site)  
II This study 
pRS551-pA IHE3034 pmatA in pRS551 [-608 to +81 
from the GTG of matA (pA)] 
II This study 
pRS551-pB IHE3034 pmatB in pRS551 [-608 to +81 
from the ATG of matB (pB)] 
II This study 
pRS551-pC IHE3034 pmatC in pRS551 [-615 to +81 
from the ATG of matC (pC)] 
II This study 
pRS551-pD IHE3034 pmatD in pRS551 [-608 to +81 
from the ATG of matD (pD)] 
II This study 
pRS551-pE IHE3034 pmatE in pRS551 [-612 to +83 
from the ATG of matE (pE)] 
II This study 
pRS551-pF IHE3034 pmatF in pRS551 [-608 to +81 
from the ATG of matF (pF)] 
II This study 
pRS551-pADtrpt IHE3034 pmatA in pRS551-∆trpt [-608 
to +81 from the GTG of matA (pA-Dtrpt)] 
II This study 
pRS551-pP1 IHE3034 pmatA in pRS551 [-121 to -56 
from the GTG of matA (pP1)] 
II This study 
pRS551-pP2 IHE3034 pmatA in pRS551 [-343 to -122 
from the GTG of matA (pP2)] 
II This study 
pRS551-pP3 IHE3034 pmatA in pRS551 [-608 to -344 
from the GTG of matA (pP3)] 
II This study 
pRS551-pP12 IHE3034 pmatA in pRS551 [-343 to -56 
from the GTG of matA (pP12)] 
II This study 
pRS551-pP23 IHE3034 pmatA in pRS551 [-608 to -122 
from the GTG of matA (pP23)] 
II This study 
pRS551-pP123 IHE3034 pmatA in pRS551 [-608 to -56 
from the GTG of matA (pP123)] 
II This study 
pRS551-pA2 MG1655 pmatA in pRS551 [-608 to +81 
from the GTG of matA (pAMG1655)] 
II This study 
pUC19 cloning vector, ApR II Yanisch-Perron et al., 
1985 
pUC19-placZ IHE3034 lacI-pRS551 rrnB T14-partial II, III, IV This study 
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lacZ in pUC19 
pUC19-pAB IHE3034 pmatA [-608 to +745 from the 
GTG of matA(A536C)] in pUC19-placZ 
III This study 
pACYC184 cloning vector, TcR, CmR II, IV New England Biolabs 
pTAL1 IHE 3034 matA under ptet in pACYC184  II, IV This study 
pTAL2 MG1655 matA under ptet in pACYC184 II, IV This study 
pBR322 cloning vector, TcR, ApR II Bolivar et al., 1977 
pHNS1 IHE 3034 hns with 660 bp upstream and 
143 bp downstream region in pBR322 
II This study 
pHNS2 MG1655 hns with 661 bp upstream and 
143 bp downstream region in pBR322 
II This study 
pCRP1 IHE 3034 crp with 299 bp upstream 
region in pBR322 
- This study 
pMAL-c2x Maltose-binding protein (MBP) fusion 
vector, malE, lacI, ptac, ApR 
II, III, IV New England Biolabs 
pBAU1 IHE 3034 matA in pMAL-c2x II, III, IV This study 
pBAU1-H2 IHE 3034 matA(A536C) in pMAL-c2x II This study 
pMAL-RCSA1 IHE 3034 rcsA in pMAL-c2x III This study 
pQE30 N-terminal 6xHistag fusion vector, pT5, 
lacO, ApR  
II, III Qiagen 
pQE30-HNS1 IHE 3034 hns in pQE30 II This study 
pQE30-RCSB1 IHE 3034 rcsB in pQE30 III This study 
pQE30-RCSB2 IHE 3034 rcsB(T168G) in pQE30, 
resulting in RcsBD56E 
III This study 
pQE30-CRP1 IHE 3034 crp in pQE30 - This study 
pQE30-MATA1 IHE 3034 matA in pQE30 - R. Pouttu, University of 
Helsinki, unpublished 
construction 
pQE60 C-terminal 6xHistag fusion vector, pT5, 
lacO, ApR 
- Qiagen 
pQE60-MATA1 IHE 3034 matA in pQE60 - This study 
pREP4 Repressor plasmid, lacI, KmR II, III Qiagen 
pGEX-6p-1 Glutathione S-transferase (GST) fusion 
vector, lacI, ptac, ApR 
- Amersham Biosciences 
pGEX-MATA1 IHE 3034 matA in pGEX-6p-1 - This study 
pGP704 Suicide vector, pir-dependent ori R6K, 
mob RP4, ApR 
I Miller & Mekalanos, 
1988 
pCVD442 Suicide vector, pir-dependent ori R6K, 
mob RP4, sacB, ApR  
I-IV Donnenberg & Kaper, 
1991 
pKO3 Suicide vector, temperature-sensitive 
oripSC101 replication origin, sacB, CmR  
- Link et al., 1997 
pKD4 kan cassette template vector for RED 
system, ApR, KmR 
- Datsenko & Wanner, 
2000 
pKD46 λ Red recombinase expression plasmid 
for RED system, temperature-sensitive 
oriR101 repA101 replication origin, γ-β-
exo under paraBAD, ApR  
- Datsenko & Wanner, 
2000 
pCP20 FLP recombinase expression plasmid 
for RED system, temperature-sensitive 
oripSC101, cI857λ, flp under λ pR, ApR, 
CmR 




Transposon vector, pir-dependent ori 
R6K, mob RP4, ApR, CmR 
II, III Biomedal 
pGEM®-T Easy Cloning vector, ApR II Promega 
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3.2. Methods used in this thesis 
The experimental procedures used in this study are described in detail in the original 
publications, and compiled in Table 6; methods not used in the publications are described in 
the Chapter 3.3. 
 
Table 6. Summary of methods used in this study. 
Method Article 
Standard DNA techniques I-IV 
Site-directed mutagenesis I-IV 
Transposon mutagenesis II, III 
DNA sequence analysis II, III 
RNA isolation II, III, IV 
Northern blotting II, III, IV 
mRNA half-life determination II 
RT-PCR II 
Real-time RT-PCR II 
Primer extension II 
5’ RACE II 
Whole-cell ELISA I, II 
Indirect immunofluorescence I 
Western blotting I, II, IV 
Colony immunoblotting II 
Screening with immunomagnetic particles II 
Serum agglutination I, II, III 
Protein expression and purification II, III, IV 
Electrophoretic mobility shift assay II, III, IV 
N-terminal sequencing II 
β-galactosidase assay II, III, IV 
Biofilm formation assay I, III 
Initial attachment assay I 
Motility assay IV 
 
3.3 Methods other than those described in the papers I - IV 
3.3.1 Hemagglutination and yeast cell agglutination assays 
Agglutination of Saccharomyces cerevisiae yeast  cells  or  the  human group O erythrocytes  
(Reagent red cells for antibody identification - DiaMed system, Alba Bioscience, UK; 
contains 11 different untreated and 11 papain-treated human group O red cells) by bacteria 
were performed as previously described (Korhonen & Finne, 1985) by mixing equal 
volumes of a suspension of PBS-washed bacteria and eukaryotic cells on cold glass slides 
placed on ice. The mixture was gently rotated for 5 min, after which bacterial agglutination 
was detected visually, and confirmed by phase-contrast microscopy using an Olympus 
CKX41 microscope.  
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3.3.2 Interactions with human epithelial cell lines 
The human cell lines used in the present study are Henle 407 (embryonic intestine, ATCC 
CCL-6), T24 (human bladder carcinoma), VK2/E6E7 (vaginal, ATCC CRL-2616), 
Ect1/E6E7 (ectocervical, ATCC CRL-2614), and End1/E6E7 (endocervical, ATCC CRL-
2615). Henle 407 were routinely cultured in Basal medium Eagle supplemented with 10% 
fetal bovine serum and 2 mM L-Glutamine; T24 cells were cultured in McCoy's 5A medium 
supplemented with 10% fetal bovine; and VK2/E6E7, Ect1/E6E7 and End1/E6E7 were 
cultured in keratinocyte serum-free medium supplemented with 0.1 ng ml-1 human 
recombinant EGF, 0.05 mg ml-1 bovine pituitary extract, and additional calcium chloride 
(final concentration 0.4 nM). Cells were maintained at 37°C in 5% CO2. 
 
For  adhesion  assays,  the  eukaryotic  cells  were  grown  on  eight-well  chamber  slides  (Lab-
Tek® II, Nalge Nunc International) or diagnostic eight-well glass slides for 1-2 days to 
approximately 70% confluence. The culture medium was removed and cells were fixed with 
cold 3.5% paraformaldehyde in PBS for 10 min or alternatively left untreated. After washing 
three times with PBS, bacterial suspension (40 µl, 5×108, 109 or 5×109 ml-1 in PBS, in 
respective eukaryotic-cell culture medium, or in DMEM) were added on the eukaryotic cells 
and incubated for 1-3 hour at 37°C, in 5% CO2. The slides were washed five times with 
PBS, fixed with methanol for 10 min, dried, and stained with 0.1% Giemsa stain. The 
adherent bacteria were examined in an Olympus BX50 or Olympus CKX41 microscope. 
3.3.3 Immunoelectron microscopy 
For immunoelectron microscopy, bacteria were grown overnight at 37°C in LB broth 
buffered with 100 mM MES (2-(N-Morpholino)ethanesulfonic acid), pH 5.5. Isopropyl-β-D-
thiogalactopyranoside (IPTG) and ampicillin, when necessary, were added at concentrtions 
of 5 µM and 100 µg ml-1, respectively. The bacteria were collected by centrifugation (2000 
rpm 10 min) and suspended in LB broth. The bacteria were prepared for immunoelectron 
microscopy as described by Pouttu et  al. (2001). Briefly, the bacteria were transferred to 
copper grids coated with Pioloform and carbon by incubating for 10 min. The immobilized 
bacteria were left to react for 45 min with anti-Mat antibodies diluted to 1:500 in PBS 
containing 0.1% BSA, and then for 45 min with 10-nm-particle-diameter gold-labeled 
protein A (Amersham Life Science) diluted to 1:65 in PBS containing 0.1% BSA. For 
contrasting the grids, the bacteria were negatively stained by floating on drops of 1% 
phosphotungstic acid in water, pH 6.5 for 1.5 min. After removal of excess fluid, microscopy 
was done with a JEOL JEM-1200EX transmission electron microscope operated at 60 kV, at 
Electron Microscopy Unit, Institute of Biotechnology, University of Helsinki. 
3.3.4 Prediction of signal peptides 
The presence of signal peptide cleavage sites in amino acid sequences were predicted by 
SignalP v3.0 based on hidden Markov models (Bendtsen et al., 2004).  
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3.3.5 Frameshift mutation of rne gene 
In order to analyze the effects of RNase E inactivation on temperature-dependent mat 
expression, the rne131 mutant allele encoding a stable, truncated form of RNase E (Kido et 
al., 1996) was chosen instead of widely used temperature-sensitive rne alleles  (rne-1 and 
rne-3071) which utilization requires compulsory temperature upshift that affects the 
endoribonucleolytic activity of the encoded mutant proteins (McDowall et  al., 1993). To 
create the rne131 mutation into the IHE 3034 chromosome, a deletion of two nucleotides 
(2295GT) resulting in a +1 frameshift was introduced into the rne gene. Briefly, the 5’ and 
3’ flanking sequences of the deletion site were amplified from IHE 3034 chromosomal DNA 
with the upstream primer 252F 5’-GTAGCGGCCGCAGATCGATAAAGAAGAGC-3’ and 
the mutagenic primer 247R 5’-TGGTTTCTTCCACCGCTGAACAGCGC-3’; and the 
mutagenic primer 246F 5’-GTAGTCGACTTACTCAACAGGTTGCGG-3’ and the 
downstream primer 253R 5’-TTCAGCGGTGGAAGAAACCAAACCGACC-3’. The PCR 
products were fused with each other by recombinant PCR and then cloned into the NotI-SalI 
site of pKO3. A previously described gene replacement method which utilizes the pKO3 
plasmid with a temperature-sensitive origin of replication (Link et al., 1997) was applied, 
and the created mutation was verified by DNA sequencing using primer 251F 5’-
CCAACCTTAAGCTACATGC-3’. 
3.3.6 Deletion of matA gene 
In-frame deletion of matA on  the  chromosome  of  the  strain  IHE  3034-Rif  was  created  by  
site-specific mutagenesis using recombinant PCR and the pir-dependent suicide vector 
pCVD442 essentially as described previously (Mobley et al., 1993). Briefly, the 5’ and 3’ 
flanking sequences of the deletion site were amplified with the upstream primer 003F 5’-
GCAGAGCTCATATCCATCCTGAGTATCG-3’ and the mutagenic primer 006R 5’-
CTTGCCTGGAGTTACTTTCCAAACCTGTAATTT-3’; and the mutagenic primer 005F 
5’- GTTTGGAAAGTAACTCCAGGCAAGTTAG-3’ and the downstream primer 004R 5’-
GCAGCATGCGTCGTAAAGGCATTGTCG-5’. The overlapping PCR products were 
purified and mixed, and a fusion product was digested with SacI and SphI, and cloned into 
pCVD442. The resulting suicide plasmid was mobilized into IHE 3034-Rif via conjugation 
from S17-1 λpir. After sucrose selection, the allelic exchange was screened by colony-PCR, 
and the correct deletion was verified by DNA sequencing using primer 014F 5’-
CATATTGACACTCATCAGG-3’.  
3.3.7 Deletion and complementation of crp gene 
The deletion of crp in the chromosome of IHE 3034-Rif was generated by using the λ Red-
based technology and linear DNA for recombination, as described previously by Datsenko 
and Wanner (2000). The kanamycin kan gene flanked by FLP recognition target (FRT) sites, 
from the plasmid pKD4, was amplified by PCR using primers 175REDF 5’-
CTCTGGAGAAAGCTTATAACAGAGGATAACCGCGCATGGTGTAGGCTGGAGCTG
CTTC-3’ and 176REDR 5’-GGCGCGCTACCAGGTAACGCGCCACTCTGACGGGATT 
ACATATGAATATCCTCCTTAG-3’ (58 nt) containing 38 nucleotides of homologous 
sequence to the region 5' and 3' of the crp gene. After electroporation of IHE 3034-Rif 
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(transformed with the pKD46 helper plasmid) by using 250 ng of DpnI digested and purified 
PCR fragment, and exchange of the wild-type crp allele with the FRT-flanked kan insertion, 
the  resistance  gene  was  eliminated  with  the  help  of  the  FLP  recombinase  encoded  on  
plasmid pCP20. The generated deletion was verified by DNA sequencing using primer 177F 
5’- CACAAAGCGAAAGCTATGC-3’. 
 
Plasmid pCRP1 was constructed by amplication of the crp coding region together with 299-
bp upstream region from the strain IHE 3034 by using the oligonucleotide primers 179F 5’-
CGCGGATCCTTGCTACTCCACTGCGTC-3’ and 180R 5’-CGGCGAATTCAAATGGCG 
CGCTACCAGG-3’, and cloning the resulting PCR product into the BamHI-EcoRI 
restriction sites of vector pBR322.  
3.3.8 Purification of His6-MatA and GST-MatA proteins 
Plasmid pQE60-MATA1 was constructed by amplication of the matA coding region from 
the strain IHE 3034 by using primers 117F 5’-GCTCCATGGGAACATGGCAAAATGATT 
ACAG-3’ and 123R 5’-CGCAGATCTCTGAACCAACTTATATAATTT-3’, and cloning 
the resulting PCR product into the NcoI-BglII restriction sites of vector pQE60. 
 
To express glutathione S-transferase (GST) -MatA fusion protein, a PCR-generated fragment 
encoding MatA from IHE 3034 was amplified by 165F 5’-GCCGGATCCGTGACATGGCA 
AAATGATTAC-3’ and 008R 5’-GCCGTCGACTTACTGAACCAACTTATATAAT-3’ 
primers, and cloned into BamHI-SalI digested pGEX-6p-1, to generate pGEX-MATA1. 
 
N- and C-terminally His6-tagged MatA proteins were purified from BL21(AI) slyD (pREP4) 
cells harbouring expression plasmid pQE30-MATA1 or pQE60-MATA1, and GST-MatA 
from BL21(DE3) (pGEX-MATA1) cells. The cells were cultivated in LB medium at various 
temperatures (20, 30 or 37°C) to mid-logarithmic phase (corresponding to an OD600 of 
around 0.5) at which point the culture temperature was reduced to 15°C or kept unchanged, 
and IPTG was added to a final concentration of 0.1 or 1 mM. After 4 h incubation, the cells 
were harvested by centrifugation and frozen at -70°C. The His-tagged recombinant proteins 
were purified under native or denaturing conditions using Ni-nitrilotriacetic acid resin 
according to the QIA express System (QIAGEN). GST-MatA was purified using 
Gluthatione Sepharose™ 4B according to manufacturer’s instructions (GE Healthcare). 
3.3.9 Purification of His6-CRP protein and electrophoretic mobility shift assay  
To express His6-CRP protein protein, a 0.6-kb BamHI/HindIII DNA fragment containing the 
crp coding sequence from IHE 3034 was amplified by 181F 5’-CGCGGATCCATGGTGCT 
TGGCAAACCG-3’ and 182R 5’-CGCGAAGCTTTTAACGAGTGCCGTAAACG-3’ 
primers and inserted between the BamHI and HindIII  restriction sites of the pQE30 vector,  
yielding the plasmid pQE30-CRP1. 
 
BL21(DE3) (pQE30-CRP1)(pREP4) cells were grown in 600 ml of LB media with 
appropriate antibiotics to OD600 of 0.7 at 30°C, and expression of the fusion protein was then 
induced for 4 h after the addition of 1 mM IPTG. Cells were harvested by centrifugation and 
frozen at -70°C. The His-tagged CRP proteins were purified under native conditions using 
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Ni-nitrilotriacetic  acid  resin  according  to  the  QIA  express  System  (QIAGEN).  Protein-
containing elution fractions, as judged by A280 absorption, were loaded into Spectra/Pro® 
dialysis membrane tube (12-14 kDa cut-off; Spectrum Laboratories) and step-wise dialysed 
into 30 mM Tris-HCl at pH 7.5–150 mM NaCl–15% glycerol. The protein concentrations 
were estimated from SDS-PAGE gels comparing intensities of stained polypeptides with 
those of BSA standards of known concentration using Tina (v2.0) image analysis program 
(Raytest Isotopenmessgeräte Gmbh). 
 
The pmatA, pmatB2 and placZ DNA fragments used for the EMSA assay were obtained by 
PCR amplification using genomic DNA from IHE 3034 as a template. The primers for 
pmatA are listed in the Table S4 of Paper II. The pmatB2 fragment was amplified by using 
primers MATB-F 5'-ATGAAAAAAAAGGTTCTGGCA-3 and 114R 5’-
GTAGCCGTTGAGTCACC-3’, and placZ using 191F 5’-TTAATGCAGCTGGCACGAC-
3’ and 190R 5’-GGCCAGTGAATCCGTAATC-3’. An equimolar mixture of the fragments 
(0.28 pmol of each) were incubated with increasing concentrations of His6–CRP in 10-μl 
reaction mixtures 10 mM Tris-HCl at pH 7.5–1 mM EDTA–50 mM NaCl–5 mM MgCl2–1 
mM dithiothreitol–0.05% Nonidet P-40–5% glycerol-0.1 mM cAMP. Following an 
incubation for 15 min at 20°C, the reactions were electrophoresed in 6% PAGE in 0.5×TBE 
at 20°C. After electrophoresis, the DNA fragments were visualized by staining with 
ethidium bromide and exposing to UV light. 
3.4 Accession numbers of the nucleotide sequences 
Table 7. Genbank accession numbers of the E. coli nucleotide sequences described in this study. 
Sequence designation Accession number Article 
mat operon region of IHE 3034 HM102365 I 
mat upstream regulatory region of IHE 3040 JN377374 II 
mat upstream regulatory region of IHE 3072 JN377375 II 
mat upstream regulatory region of BEN79 JN377376 II 
mat upstream regulatory region of BEN374 JN377377 II 
mat upstream regulatory region of Nissle 1917 JN377378 II 
mat upstream regulatory region of 285 JN377379 II 
mat upstream regulatory region of 789 JN377380 II 
matA coding region of BEN374 JN377381 - 
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4 Results and discussion 
In this thesis work, the O18ac:K1:H7 meningitis isolate E. coli IHE 3034 was selected as the 
model organism to study functions of Mat fimbria and regulatory networks controlling the 
expression of the mat operon. The strain was originally isolated in Finland in 1976 from a 
case of fatal late onset neonatal meningitis (Korhonen et al., 1985; Selander et al., 1986), 
and has been thereafter further characterized in various studies in Helsinki (e.g. Pouttu et al., 
1999 and 2001) as well as by research groups elsewhere (e.g. Bauchart et al., 2010; Dobrindt 
et al., 2003; Moriel et al., 2010; Nagy et al., 2005; Nougayrède et al., 2006; Sjöström et al., 
2009b; Wang & Kim, 2000). IHE 3034 belongs to one of the best characterized NMEC 
strains and to the virulence-associated phylogenetic group B2. To facilitate functional 
genetic studies on Mat fimbriae, we first sequenced the six-gene mat operon and its flanking 
sequences of the E. coli IHE 3034 chromosome (Genbank accession no. HM102365; Table 
7). Moreover, the complete 5.11-Mb genome sequence of IHE 3034 consisting of 4,757 
translatable open reading frames became available during the last part of my thesis work 
(Moriel et al., 2010). To study the differential expression of mat genes, the laboratory K-12 
strain MG1655, in which Mat expression had not been detected although the strain has a 
seemingly intact mat gene cluster (Pouttu et al., 2001; and this thesis work), was analyzed 
for comparison. M1655 is an A-phylogroup strain and the first E. coli isolate whose genome 
(4.64 Mb) was sequenced (Blattner et al., 1997). The IHE 3034 strain contains two 
extrachromosomal plasmids (Achtman et  al., 1983) that are absent in MG1655 strain, and 
carries 0.47 Mb more chromosomal DNA than MG1655. This DNA is primarily organized 
to various IHE 3034-specific genomic and pathogenicity islands that encode many candidate 
virulence factors, such as the S fimbria, the K1 capsule, type II and VI secretion systems, 
several siderophores, and the siderophore receptor IroN (Dobrindt et al., 2003; Moriel et al., 
2010). On the other hand, 202 genes present in MG1655 were not detectable in the genome 
of IHE 3034 (Dobrindt et  al., 2003). However, the mat gene cluster in the two strains is 
located at the same chromosomal site (304373-311212IHE 3034 and 303719-310560MG1655) in 
both strains and has a sequence identity of 97.8%.  
4.1 The common colonization factor Mat fimbria promotes biofilm formation 
4.1.1 Assessing potential Mat fimbriae-mediated adherence on eukaryotic cells (this 
thesis) 
In search for potential target molecules for Mat fimbriae-mediated adhesion, I first focused 
on eukaryotic cells. Previous study had shown that E. coli expressing Mat fimbriae does not 
agglutinate human O group erythrocytes, neither untreated nor treated with endo-β-
galactosidase, neuraminidase, trypsin, or pronase to expose cryptic carbohydrates on red 
blood cell surface (Pouttu et  al., 2001). Testing with mannan-rich yeast (Saccharomyces 
cerevisiae) cells and panels of untreated or papain-treated human O group erythrocytes 
carrying various blood type antigens (Rhesus, Kell, Duffy, Kidd, Lewis, MNS, P, Lu, Wr 
among others) gave similar result; Mat fimbriae-expressing K-12 recombinant bacteria and 
flagellum-, S-fimbria-, and type 1-fimbria-negative IHE 3034-79 did not agglutinate any of 
the cells tested (data not shown) suggesting that common carbohydrates of human and yeast 
cell surfaces are not recognized by the Mat fimbria. Thus, the approaches that were 
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successful in characterizing P, type 1, S, and Dr fimbriae binding did not apply to the Mat 
fimbria. 
 
Next, it was set out to investigate whether Mat fimbria promotes adherence to cultured 
human epithelial cells. IHE 3034-Rif and isogenic Mat fimbria-deficient matB::cat 
derivative, as well as laboratory K-12 strain HB101 harbouring plasmid pMAT6, encoding 
Mat fimbriae from IHE 3034, or vector pSE380 were evaluated for their ability to adhere to 
immortalized human intestinal (Henle 407), bladder (T24), vaginal (VK2/E6E7), 
ectocervical (Ect1/E6E7), and endocervical (End1/E6E7) epithelial cell lines. Surface 
expression of Mat fimbriae did not induce significant adherence to any of the tested cell lines 
(data not shown). While this thesis work was in progress, two other research groups 
addressed the role of ECP fimbriae in host cell adhesion and showed that the fimbriae 
mediate adherence to human cervix (HeLa), colonic (HT-29), and larynx (HEp-2) epithelial 
cell (Avelino et  al., 2010; Lasaro et al., 2009; Rendón et al., 2007; Saldaña et al., 2009). 
Differences in receptor specificity of the adhesive fimbria subunit (Mat versus ECP), 
bacterial strains (NMEC versus e.g. EPEC and EHEC), and cultured eukaryotic cells used, or 
experimental conditions may explain our divergent outcome. 
4.1.2 Mat fimbriae encoded by matABCDEF gene cluster mediate temperature-
dependent biofilm formation (I, II, III and this thesis) 
It was next investigated whether Mat fimbria contributes to E. coli biofilm formation ability 
on inert surfaces. Using different target surfaces [hydrophilic glass and hydrophobic 
polyvinyl  chloride  (PVC),  polystyrene,  and  polypropylene],  different  media  (LB broth  and  
M63 minimal medium supplemented with glucose and casamino acids) and temperature 
conditions (20 and 37°C), we found that the clinical isolate IHE 3034 formed a maximum 
biofilm on hydrophobic PVC surface when grown in M63 medium at 20°C (Fig. 2 of I). 
Contrary to IHE 3034, the Mat fimbriae-negative laboratory K-12 strain MG1655 was 
unable to establish biofilm under these conditions. No biofilm on PVC surface was detected 
with the strains when the growth temperature was elevated to 37°C.  
 
I assessed the contribution of the entire matBCDEF region and each putative structural mat 
gene on temperature-dependent biofilm formation by IHE 3034. Earlier work by Pouttu and 
co-workers (2001) had shown that MatB is a major structural subunit of the Mat fimbria, and 
complementation assays of matB-deficient mutant also indicated involvement of matA and 
matC in the surface expression of the fimbria. The N-terminal signal sequence directs 
secretory proteins cross the cytoplasmic membrane to the periplasm via the general secretion 
pathway (Sec-pathway) (Natale et al., 2008). In silico analysis using SignalP 3.0 (Bendtsen 
et al., 2004) indicated the presence of a cleavable N-terminal signal sequence in matB-F 
gene products but not in the predicted MatA sequence (data not show). This suggests that 
MatC,  MatD,  MatE,  and  MatF  are  either  a  periplasmic  or  an  outer  membrane  protein,  and  
may therefore directly be dedicated to the assembly of the filamentous Mat structures, as 
MatB fimbrillin, whereas MatA may be a cytoplasmic protein. To assess the participation of 
matB-F genes both in Mat fimbria biogenesis and biofilm formation, I inactivated each of 
these genes and the entire matBCDEF locus by nonpolar in-frame deletion. Whole-cell 
ELISA using anti-Mat fimbria antibodies revealed a significant reduction in surface 
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expression of Mat fimbriae in the deletion derivatives compared with the wild-type parent 
strain, IHE 3034-Rif (in each case p <0.001, unpaired t test; Fig. 1 of I). The defect in Mat 
fimbriation was rescued by plasmid-derived expression of the corresponding gene, or in the 
case of matB-F deletion strain by insertion of the wild-type alleles back into the native 
chromosomal location. Functional analysis of the knockout mutants showed a complete loss 
of biofilm formation on PVC without affecting planktonic growth (Fig. 2 of I). In line with 
our results, a recent biofilm mutant screen on the EHEC O157:H7 strain EDL933 identified 
matE (or ecpD) to be involved in biofilm formation on polystyrene surface (Puttamreddy et 
al., 2010). Similarly, another study showed the critical role of matB (or ecpA) for the ability 
of EDL933 to form biofilm (Garnett et al., 2012). 
 
Time course analysis of surface attachment demonstrated that Mat-defective cells were 
capable of reversible binding on PVC but unable to form a dispersed monolayer (Fig. 4 of I). 
The other known in vitro expressed cell-associated appendages of IHE 3034, type 1 fimbria, 
S fimbria, and flagellum (Selander et al., 1986), were not involved in the establishment of 
the biofilm (Fig. 3 of I). Using indirect immunofluorescence, whole-cell ELISA, and 
Western blotting I showed that the average Mat fimbriae expression level in the cell 
population stayed constant throughout the transition from planktonic, free-floating phase to 
mature biofilm (Fig. 4 and 5 of I). This suggests that Mat fimbriae are not differentially 
expressed at certain stage of biofilm development. 
 
Sequence comparison between the NMEC isolate IHE 3034 and the commensal K-12 strain 
MG1655 revealed that the predicted MatB-F proteins contains 27 amino acid differences in 
total (data not shown) that may affect the biogenesis and the functional properties of the 
fimbriae, as shown for type 1 fimbriae (Chen et al., 2009; Pouttu et al., 1999; Schembri & 
Klemm, 2001; Sokurenko et al., 1998). To find out whether the identified Mat-mediated 
biofilm formation is specific for the NMEC host, and to assess if the allelic variation in Mat 
proteins affects biofilm-forming ability, I introduced expression plasmids encoding MatB-
FIHE 3034 and MatB-FMG1655, into the wild-type MG1655 and the IHE 3034 matBCDEF 
mutant, and compared their effects on biofilm formation (Fig. 2 of I). Notable, ectopic 
expression of matB-F genes, derived either from IHE 3034 or MG1655, promoted biofilm 
growth in the non-NMEC host MG1655 at 20°C. This shows that Mat-mediated biofilm 
growth is independent on B2-phylogroup or NMEC -specific factors. Moreover, the two Mat 
fimbria variants did not differ in their capacity to support biofilm growth demonstrating that 
also M1655 harbours functional matB-F genes, and has thus retained the capability to 
express the fimbriae. However, while Mat fimbriae expression on the bacterial cell surface 
was observed at 20°C and 37°C after induction, biofilm was only produced at 20°C in both 
MG1655 and IHE 3034 matBCDEF backgrounds. This result illustrates that other 
temperature regulated factors than Mat fimbriae are critically involved in the biofilm 
process.  
 
Temperature is a top-level cue for E. coli and other host-associated bacteria that signal the 
entry of the bacteria into host niche or the exit from a host into environment. The transition 
between ambient low temperature and body temperature have shown to result in dramatic, 
genome-wide changes in E. coli transcriptome, including differential expression of various 
genes associated with biofilm formation, outer membrane biogenesis, metabolism, and 
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transcriptional regulation as well as a large number of uncharacterized genes (White-Ziegler 
et al., 2007; White-Ziegler et  al., 2008). One possibility for the the lack of Mat-fimbriae-
dependent biofilm at 37°C is downregulation of other cell-surface associated structures 
interacting with the Mat fimbriae and/or the target surface. The second possibility for 
inability to form multicellular, sessile communities at 37°C despite induced Mat fimbriae 
expression is a presence of thermoregulated factors that mask or interfere with the function 
of short surface-located adhesins or signal receptors, and thus prevent biofilm formation by 
disturbing cell-surface initial interactions, close cellular contacts or cell-cell communication. 
Capsular polysaccharides constitute the outermost layer of the cell envelope and can act as a 
shielding factor of this nature (Schembri et al., 2004). Further, certain capsulated E. coli 
strains can antagonize biofilm formation by a mechanism distinct from steric hindrance of 
surface adhesins. These strains, including IHE 3034, were shown to significantly release 
capsular antigens into the growth medium which inhibited biofilm development by 
weakening cell-surface contacts and cell–cell interactions (Valle et al., 2006). The capsular 
K1 antigen, a 2,8-linked polysialic acid, is produced at host temperature but not at the low 
temperature of 18 or 22°C (Bortolussi et al., 1983; Ørskov et al., 1984). However, the 
laboratory strain MG1655 and other K-12 strains lack O-antigen (Stevenson et al., 1994) and 
are also incapable of producing capsule. As Mat fimbriae-mediated biofilm formation was 
temperature-dependent also in this genetic background, the cell-surface associated or 
released K1 capsular polysaccharides cannot account the phenomenon.  
  
Next, the role of the first gene of the operon, matA, in biofilm formation was investigated. 
matA is predicted to encode a protein of 196 amino acids that contains a putative, C-terminal 
helix-turn-helix (HTH) DNA-binding motif (Pouttu et  al., 2001; see Fig. 3A). The 
replacement of A166 in the scaffold helix (α2) and H179 in the recognition helix (α3) by 
proline was designed to disrupt the proper folding of the helices and consequently DNA 
binding (Barlow & Thornton, 1988). In both mutant strains, the proline substitution 
completely abolished surface expression of Mat fimbria (Fig. 3B) demonstrating the 
importance of functional MatA for Mat fimbriae expression. As expected from the previous 
results, the matA mutant lost its ability to biofilm growth, and the biofilm-forming phenotype 
was restored by single-copy chromosomal complementation of the mutation (Fig. 3C). 
Similar to matB-F genes, in trans overexpression of matA was not enough for biofilm 
formation at 37°C (Fig. 3C; Fig. 1 of III). A more detailed analysis of MatA and 


























Figure 3. Proline substitutions at the HTH-domain of MatA abolish Mat fimbriae expression and 
biofilm formation in IHE 3034. (A) Schematic representation of MatA protein. The putative LuxR-type 
tri-helical helix-turn-helix (HTH) DNA-binding motif is indicated as a light grey box, and alpha helices 
of HTH are shown as dark grey boxes. The location of introduced A166P (resulting from G496C 
nucleotide substitution) and H179P (resulting from A536C nucleotide substitution) substitutions are 
indicated by arrowheads. (B) Surface expression of Mat fimbriae by the parent strain IHE 3034-Rif 
and matA mutants. Bacteria were analyzed by whole-cell ELISA with anti-Mat fimbria serum as 
primary antibodies after growth in LB medium at 20 and 37°C. The data represent means and 
standard deviations of two independent experiments. (C) Biofilm formation by IHE 3034-Rif 
derivatives after growth for 48 h in M63 medium in PVC microtitre plate wells at 20 or 37°C. The 
biofilm-associated cells were visualized by CV staining. The data shown were reproduced in three 
independent experiments, and error bars represent standard deviation. Assays with the Mat fimbriae-
deficient IHE 3034 matBCDEF deletion mutant is shown for comparison. 
 
4.1.3 The Rcs phosphorelay system is involved in Mat fimbriae-mediated biofilm 
formation (III) 
Biofilm development is a complex, multifactorial genetic program, and to better understand 
the genetics of this process, IHE 3034 was subjected to mini-Tn5 transposon mutagenesis 
and the resulting library was screened for mutants exhibiting an altered biofilm phenotype in 
conditions supporting Mat-mediated biofilm formation. After testing of 4,418 individual 
transposon insertion mutants for their ability to develop biofilm on PVC, 32 candidate 
biofilm-forming mutants conferred a reproducible phenotype (Table 3 of III). Using direct 
DNA sequencing, the transposon insertions were mapped to 15 distinct genes, from which 
11 were involved in lipopolysaccharide (LPS) biosynthesis. Many of these LPS-genes has 
46 
 
previously been linked to reduced biofilm capability in E. coli (Amini et al., 2009; Beloin et 
al., 2006; Niba et al., 2007; Puttamreddy et al., 2010). Next, we further screened the 
candidate mutants for general metabolic defects by measuring growth yield in M63 medium 
after biofilm growth and comparing with that of the parental strain. After this elimination, 
which included all LPS-defective mutants, eight mutants were retained. The expression 
status of the Mat fimbriae was tested by serum agglutination. Five of the mutants had lost 
both the ability to surface-express the fimbriae and to form biofilm: two independent 
insertions were identified in matA,  and  three  insertions  were  in  the  coding  region  of  rcsB 
gene at two different locations.  
 
This result revealed a new regulatory cascade required for Mat fimbria expression as RcsB is 
a  response  regulator  of  the  Rcs  phosphorelay  signalling  pathway  that  responds  to  various,  
mainly stress-related, environmental cues (Clarke, 2010). Overexpression of rcsB from a 
multicopy plasmid restored Mat mbria production and biofilm formation at 20°C, however, 
the strain did not gain the ability to display multicellular behaviour at  37°C (Fig.  1 of III).  
Further, when the high-copy-number plasmid encoding Mat fimbriae was transformed into 
rcsB mutant, the derivative behaved in manner similar to that of the wild-type strain. Given 
that RcsB is a pleiotropic regulator that controls various biofilm-associated genes (Ferrières 
& Clarke, 2003; Hagiwara et al., 2003; Oshima et al., 2002), bypassing the requirement of 
rcsB gene for biofilm formation is noteworthy. For instance, RcsB is absolutely required for 
colonic acid expression (Brill et  al., 1988; Gottesman et al., 1985). This suggests that 
colonic acid is not compulsory for Mat-mediated biofilm formation and highlights the 
principal role of Mat fimbriae in the development of biofilm by IHE 3034.  
 
One of the mutants with reduced biofilm capability possessed transposon within 
ECOK1_3592 (tRNAMet) gene and showed moderate reduction in Mat fimbria expression. 
IHE 3034 carries ten loci for tRNAMet, hence the defect in the mutant likely results in poor 
transcription of the adjecent genes: argG, which encodes the arginosuccinate synthase 
involved in the arginine biosynthetic pathway, and ECOK1_3591 encoding a conserved 
hypothetical protein (also known as RimP). In E. coli K-12, this tRNAMet locus, metC, forms 
multicistronic operon with rimP-nusA-infB genes (Régnier & Grunberg-Manago, 1989) and 
rbfA-truB-rpsO-pnp genes (Sands et al., 1988). The genome of IHE 3034 harbours similar 
operon structures and thus the inserted mini-Tn5 may have a polar effect on these genes. 
Recently, screening of biofilm mutants in Pseudomonas aeruginosa PA14 identified over a 
half of these genes, namely argG, nusA, rbfA, truB, and pnp, in connection with reduced 
biofilm production (Müsken et al., 2010).  
 
The last two transposon mutants, mprA and rfbA, displayed enhanced biofilm phenotype. 
MprA (also known as EmrR) represents a third transcriptional regulator identified in this 
genetic screen. Northern blotting and serum agglutination confirmed that Mat fimbriae 
expression had remained intact in the mprA mutant (Fig. 2 and Table 3 of III). MprA 
represses the transcription of the chromosomal emrRAB multidrug resistance gene cluster, 
and the disruption of mprA leads to overexpression of the EmrAB pump (Lomovskaya et al., 
1995) which may explain the moderately enhanced biofilm phenotype of mprA transposon 
mutant. Efflux pumps are active in bacterial biofilms and highly upregulated during biofilm 
growth (Kvist et al., 2008). Their inactivation, including EmrAB, has been shown to abolish 
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biofilm formation (Kvist et al., 2008; Matsumura et al., 2011). EmrAB also aids to pump out 
bile salts, detergents that disrupt biological membranes (Thanassi et al., 1997). Recently, it 
was shown that the EmrAB pump has role in acid survival of E. coli (Deininger et al., 2011), 
a mechanistic explanation however remains lacking.  
 
The rfbA mutation prevents biosynthesis of dTDP-L-rhamnose, which is an important 
precursor of cell wall polysaccharides, e.g. the IHE 3034 O18ac antigen (Selander et al., 
1986) has a L-rhamnose residue in the linear backbone of the repeating tetramer unit (Gupta 
et al., 1984). rfbBDAC gene cluster encodes the four enzymes commited to biosynthesis of 
dTDP-L-rhamnose. A glucose-1-phosphate thymidylyltransferase RfbA is responsible for 
the first enzymic step, which is the formation of dTDP-D-glucose from glucose-1-phosphate 
and dTTP (Samuel & Reeves, 2003). IHE 3034 harbours two genes for glucose-1-phosphate 
thymidylyltransferase, one in the rfbBDAC locus and the other clustered with a second rfbB 
gene and a rfe–rff enterobacterial common antigen locus. The two RfbA proteins share 66% 
amino acid identity. However, the phenotypic change of the rfbA transposon mutant 
indicates that the second rbfA gene cannot complement the mutation.  
 
Taken together, our genetic screen for biofilm mutants was not saturating but we were able 
to identify several mutants affecting biofilm formation by IHE 3034. The most interesting 
gene identified as biofilm-important is rcsB, which encodes a response regulator of the Rcs 
phosphorelay singaling pathway. The loss of Mat fimbriation in rcsB mutant and the 
recovery of biofilm phenotype after ectopic expression of Mat fimbriae strongly indicate that 
RcsB affects the temperature-dependent biofilm formation by IHE 3034 primarily at the 
level of Mat fimbriae expression. Subsequent characterization of one of the three rcsB 
mutants is described in Chapters 4.2.2 and 4.2.4. 
 
It should be noted that our mutagenesis screen and functional analysis of transposon mutants 
as well as type 1 fimbria, S fimbria, and flagellum -deficient derivatives were based on one-
time point measuring the staining of the adherent biomass. This approach is very effective 
for assessing bacterial attachment and large-scale screening for mutants as it identifies the 
phenotypes that differ in terms of the extent of the biofilm formation. However, without 
performing the assay over several time points, it does not reveal the kinetics of attachment 
and biofilm development. The other drawback is that CV staining does not take the three-
dimensional structure of the formed biofilm into account, e.g. flat and tightly packed 
structures or high and porous biofilms may bind equal amounts of stain and look similar in 
the spectrophotometric determination of CV. For instance, a colonic acid-deficient E. coli K-
12 derivative had slower biofilm growth and formed more collapsed biofilm structure 
compared to wild-type but after a long-term incubation it closely resembled the wild-type 
strain in CV analysis (Danese et al., 2000).  
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4.2 The regulatory network of Mat fimbriae expression and a motile-to-
adhesive transition 
4.2.1 The expression of fimbrillin matB mRNA is dictated by temperature-responsive 
mat promoter and involves mRNA processing (II) 
To characterize the expression of the mat operon in IHE 3034, I first performed Northern 
blot analysis with probes specific for each mat gene  (Fig.  3  of  II).  Only  a  probe  
complementary to the major subunit gene matB detect a monocistronic transcript, 0.67 kb in 
length, in the RNA harvested from logarithmic-phase culture of IHE 3034-cells grown at 
20°C. Subsequent analysis of cotranscription by RT-PCR revealed that one large 
polycistronic transcript, matABCDEF, is transcribed from the mat gene cluster (Fig. 3 of II). 
In line with this result, multicopy lacZ reporter analyses of promoter activities driven by 
upstream region of each mat gene showed that the transcriptional fusion pA encompassing 
the matA upstream region exhibited a high level of β-galactosidase activity, whereas the 
expression of the other reporter fusions, pB to pF, were at the level of the vector control (Fig. 
4 of II). Thus, we were unable to detect additional regulatory regions that would have been 
active under the test conditions. Quantification of the transciption level of the individual mat 
genes by real-time RT-PCR revealed that the transcription of the mat operon is highly polar 
(Fig. 3 of II) suggesting that differential gene expression for the production of Mat fimbriae 
is achieved through partial termination, processing and/or differential stability of mRNA 
segments of the polycistronic transcript. The sequence immediately downstream of the matB 
stop codon contains two predicted stem-loop structures. The latter putative secondary 
structure has features of an intrinsic, Rho-independent transcriptional terminator 
(d'Aubenton Carafa et  al., 1990), which suggests that transcription of matB can be 
terminated immediately downstream of the open reading frame.  
 
The results above indicate that the matB mRNA is not transcribed from a separate promoter 
but rather is processed from matAB and/or matABCDEF precursors. The processing site was 
mapped to the matA-matB intergenic region by primer extension (Fig. S2 of II). RNase E is a 
principal endonuclease in E. coli and involved in regulation of several fimbrial operons 
(Balsalobre et al., 2003; Nilsson & Uhlin, 1991; Nilsson et al., 1996). To test whether it is 
also recruited in the maturation of the matB transcript, I introduced the silencing rne131 
mutation (Kido et al., 1996; Lopez et al., 1999) in the genome of IHE 3034 and evaluated its 
effect on matB mRNA profile. The RNase E-deficient cells had higher intracellular levels of 
matB transcripts, including higher molecular weight transcripts than the monocistronic matB 
mRNA (Fig. 4). However, the major 0.67-kb mRNA is the same species as observed for IHE 
3034 wt. This indicates that the maturation of the matB transcript is independent of Rnase E, 
as in the case of F1845 and CFA/I fimbrillin mRNAs (Bilge et al., 1993; Jordi et al., 1993). 
The roles of other endoribonucleases, such as RNase III, RNase G, or RNase P (Deutscher, 





Figure 4. Processed matB mRNA accumulates in rne131 
mutant. Northern blot analysis of RNA harvested from wild-
type IHE 3034 and rne131 mutant strain that produces 
truncated, nonfunctional RNase E lacking the noncatalytic 
C-terminal region. Northern blots were performed with 
matB-probe on 2.5 µg of total RNA isolated from cells 
grown in LB to mid-logarithmic (L) and stationary (S) 
phases at 20°C and 37°C. The position of the 
monocistronic matB message is indicated with arrows. The 
lenght (bp) of DIG-labelled RNA markers are shown on the 




The expression of the transcriptional fusion pA-lacZ was stronger at 20°C than at 37°C (Fig. 
4 of II),  which agrees with the Nothern blotting analysis of matB mRNA (Fig. 4; Fig. 3 of 
II). The temperature sensitivity was not significantly affected by the previously observed 
temperature response of the weak transcriptional terminator trpt in the lacZ leader sequence 
(Liang et al., 1998; Repoila & Gottesman, 2001). Elucidation of the transcriptional initiation 
sites identified three different 5′-termini upstream of matA (see Fig. 5), from which the 
second (T2) transcriptional start site is preceded by strong -35 and -10 promoter motifs (Fig. 
S4 of II) and was associated with the highest transcriptional initiation activity (Fig. 4 of II).  
4.2.2 MatA and RcsB cooperatively activate the mat promoter (II, III) 
The lack of N-terminal signal peptide and the presence of functional, tri-helical HTH domain 
in  the  predicted  MatA protein  as  well  as  Mat-fimbriae-deficient  phenotype  of  matA HTH-
mutants (see Chapter 4.1.2) strongly indicate that MatA is a non-structural protein that has a 
regulatory function in mat expression. Northern blotting demonstrated that IHE 3034 matA 
mutants had completely lost capacity to accumulate matB mRNA (Fig. 6 of II). 
Chromosomal single-copy complementation of the matA substitution restored the the level of 
matB mRNA to that of wild-type whereas a constitutive, ectopic expression of MatAIHE 3034 
in the mutant strain resulted in a highly elevated accumulation of matB mRNA exceeding of 
the temperature and growth phase constraints. Also MatAMG1655 variant, which differs in six 
residues compared to MatAIHE 3034, complemented the mutation but had lower capacity to 
enhance matB transcription at 37°C. In MG1655, overexpression of matA did not activate 
matB expression. 
 
The Mat-fimbria- and biofilm-defective rcsB transposon mutant acted as matA HTH-mutants 
in Northern blotting analysis as no matB mRNA was  detected  in  the  RNA harvested  from 
rcsB cells grown at 20°C (Fig. 2 of III). Complementation of rcsB using multicopy plasmid 
encoding wild-type allele (identical between IHE 3034 and MG1655) revealed that the trans-
regulatory activity of RcsB differs from that of MatA; in trans overexpression of RcsB 
restored the transcription of matB to, but not beyond, normal levels. Subsequent 
complementation analysis demonstrated that neither MatA nor RcsB protein can functionally 




For monitoring the influence of MatA and RcsB on transcription initiation from the mat 
promoter, I inserted two putative regulatory sequences, pA and pAB,  downstream  of  
transcriptional terminators and upstream of the promoterless lacZ gene, and integrated these 
constructs into lac locus  of  matA(A536C) and rscB::Tn5 mutants  as  well  as  their  parental  
strains. Both pA and pAB fragment encompasses 0.6 kb of 5’ upstream region of matA 
containing three transcription start points. The longer pAB further extends beyond the matA 
coding region, designed to mimick the early-stage of matB transcription (see Fig. 5). Both 
pA- and pAB-lacZ promoter fusions showed significant temperature-responsive transcription 
initiation (p <0.005) in the wild-type background, and comparison of their expression 
profiles indicated the presence of downstream regulatory element (DRE) lying downstream 
of mat promoter (Fig. 7 of II; Fig. 3 of III). The DRE has an effect of reducing the level of 
transcription that reaches matB. This putative DRE exerted a repressive effect that was 
notably stronger at nonpermissive temperature of 37°C than at 20°C resulting only basal 
levels  of  expression  from  the  pAB-lacZ promoter fusion at 37°C. β-galactosidase activity 
measurements directed by the pAB-lacZ fusion demonstrated that no induction of 
transcription occurred at 20 and 37°C in cells lacking a functional MatA or RcsB. In 
Figure 5. An outline of the IHE 3034 mat DNA fragments pA and pAB used to construct single-copy 
transcriptional lacZ fusions. Right-angled arrows indicate the three transcription start sites, and a 
vertical arrow shows the 5’ end of monocistronic matB mRNA identified in this study. The numbers in 
the upper scheme correspond to the distances from the translational start of matA or matB. The 
location of introduced A536C missense mutation in chromosomal matA and matA in the pAB 
fragment is indicated by a black triangle in the upper scheme. The lower scheme shows a 
promoterless lacZ reporter at the lac locus in the chromosome of IHE 3034. The native lacI-lacZ 
intergenic region was replaced with a fragment of pRS551 that contains a transcription termination 
region with four rrnB T1 terminators (stem-loop symbols), and a promoter cloning site BamHI (grey 
triangle). The weak trpt terminator in the lacZ leader sequence is indicated as a grey stem-loop.  
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contrast, deletion of genes known to be involved in the modulation of the phosphorylation 
state of the transcription factor RcsB, namely rcsC, rscD as  well  as  the  ackA-pta genes 
(Fredericks et al., 2006; Schmöe et al., 2011; Takeda et al., 2001), did not decrease the pAB 
reporter expression. These results indicate that the RcsB activity is controlled by an 
alternative unknown phosphoryl donor, as proposed by others (Fredericks et  al., 2006; 
Majdalani & Gottesman, 2005; Majdalani et al., 2005), or the activation of mat promoter is 
independent of RcsB phosphorylation and instead the activity of RcsB is modulated by 
interaction with other transcriptional regulators. Consistent with Northern blot results (Fig. 6 
of II; Fig. 2 of III), plasmid-derived RcsB was unable to enhance the promoter activity over 
normal levels whereas overexpression of matA caused high upregulation of promoter 
expression at both temperatures (Fig. 7 of II; Fig. 3 of III). Thus, MatA autoregulates its own 
expression through a positive feedback loop that necessitates the presence of RcsB response 
regulator. The connection between MatA and RcsB was shown to be unidirectional as MatA 
had no regulatory activity on rcsDB and rcsB transcription initiation or accumulation of rcsB 
mRNA (Fig. 3 of III).  
4.2.3 The mat operon is under the repressive action of H-NS (II) 
Ectopic expression of matA bypassed  the  temperature  control  of  the  mat promoter, which 
suggests that activation by MatA results from competition with regulator(s) that repress(es) 
transcription at 37°C. Employing mini-Tn5 transposon mutagenesis and enrichement with 
immunomagnetic particles, we identified the nucleoid-associated protein H-NS, a well-
characterized pleiotropic regulator of E. coli (Dorman, 2004; Stoebel et al., 2008), as a 
repressor of mat expression in IHE 3034. The H-NS deficiency elicited upregulation of all 
the six mat genes at both temperatures (Fig. 10 and S6 of II). The matB transcription and the 
mat promoter  activity  in  H-NS-deficient  cells  resembled  the  patterns  seen  in  the  matA 
overexpression hns+ derivative while the functional inactivation of MatA by the H179P 
substitution in the hns background decreased the transcription initiation and the mRNA 
accumulation (Fig. 11 of II). The expression profiles of single-copy pA- and pAB-lacZ 
promoter fusions in hns mutant indicated that the temperature-responsive negative effect of 
DRE is largely H-NS-mediated. It has been previously shown that DREs located in eltAB, 
kpsMT, and proU loci are crucial for temperature-dependent repression by H-NS 
(Bouffartigues et al., 2007; Xue et al., 2009; Yang et al., 2005). Together, the results of this 
thesis demonstrate that MatA acts as an antirepressor overcoming the blockade exerted by 
H-NS but also has an additive effect on the mat promoter activation. 
 
As descibed in Chapter 4.1.2, the K-12 strain MG1655 has presumably a cryptic but 
functional mat operon. The finding of H-NS prompted us to test whether this global 
repressor silences the mat expression also in K-12. The inactivation of hns in MG1655 
abrogated the tight repression of mat operon and enabled the surface expression of Mat 
fimbriae at both 20 and 37°C. However, the induction of matB transcription was notably 
stronger at 20°C as compared to the transcription at 37°C (Fig. 10 of II), and the reason for 
this was traced to the less effective MatAMG1655 variant that is unable to further enhance 
matB expression at 37°C in the MG1655 hns mutant. 
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4.2.4 MatA, RcsB and H-NS as well as CRP-cAMP regulators directly interact with the 
mat regulatory DNA (II, III and this thesis) 
The identified regulators of mat operon, MatA, RcsB, and H-NS, can exert their regulatory 
function by direct binding to a mat promoter or indirectly by affecting expression of another 
regulatory gene(s) which, in turn, affect(s) expression of the mat operon. To determine 
whether MatA, RcsB, and H-NS affect mat expression by a specific interaction with the mat 
regulatory region, the proteins were purified for electrophoretic mobility shift assays 
(EMSAs). Our numerous attemps to produce purified, soluble recombinant N- or C-
terminally histidine-tagged MatA or GST-MatA failed. However, the corresponding genes 
complemented the matA(A536C) mutation in vivo indicating  that  a  small  fraction  of  the  
recombinant proteins were properly folded (data not shown). To improve the solubility of 
MatA, the protein was expressed as a fusion protein carrying at its N-terminus the effective 
solubility-enhancing 44-kDa maltose-binding protein (MBP) (Kapust & Waugh, 1999). The 
majority of MBP-MatA was present in an insoluble form in the cells, but extensive 
optimization of expression conditions resulted in production of soluble fusion protein in 
quantities enough for functional studies. The chaperonin GroEL involved in the correct 
folding of nascent proteins (Buchberger et al., 1996) co-purified at equal relative amounts 
along with the His6-,  GST-. and MBP-MatA preparations (Fig.  S10 of II;  data not shown).  
MBP-RcsA and His-tagged RcsB, a constitutively active RcsBD56E (Gupte et al., 1997), and 
H-NS were purified without problems. 
 
EMSA demonstrated that MBP-MatA bound in a concentration-dependent and a 
temperature-independent manner to the pmatA fragment, containing the primary 
transcriptional start site T2 upstream of matA (see Fig. 6A), and the binding was diminished 
by proline substitution at the HTH-domain (H179P) of MBP-MatA (Fig. 12 and S7 of II). 
The pmatA promoter fragment was also bound by RcsBD56E,  RcsB,  and  H-NS  but  not  by  
RcsA or MBP (Fig. 12 and S7 of II; Fig. 4 of III; Fig. 4 of IV). The binding of RcsBD56E and 
RcsB to the mat regulatory DNA presumably involves a potential 14-bp RcsAB box 
upstream  of  the  transcriptional  start  site  T2  (see  Fig.  6A).  In  line  with  this,  site-specific  
mutations of conserved nucleotides in the RcsAB box resulted in total loss of mat promoter 
expression demostrating the importance of the box for initiation of mat transcription (Fig. 4 
of  IV).  None  of  the  purified  proteins  showed  efficient  shifts  with  a  pmatB fragment 
harbouring sequences surrounding the matA-matB intergenic region and the 5’ processing 
site of matB mRNA. These findings are in agreement with the multi- as well as single-copy 
lacZ reporter analyses, which indicated that the matB mRNA  is  not  transcribed  from  a  
separate promoter but is rather originating from the main promoter upstream of the operon. 
 
Two high-throughput analyses of distribution of binding sites for CRP along the E. coli 
genome, utilizing method of ChIP-chip (chromatin immunoprecipitation combined with 
microarray hybridization) and an improved genomic SELEX (systematic evolution of 
ligands by exponential enrichment), identified CRP-binding sites in the mat operon, one 
located upstream of matA (Grainger et al., 2005) and the other within matB coding region 
(Shimada et al., 2011) (see Fig. 6A). These results suggest that the signal transduction 
system CRP-cAMP,  in  addition  to  Rcs  system,  might  have  a  role  in  the  regulation  of  Mat  
fimbriae expression. Previous studies have demonstrated that multiple chaperone-usher 
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fimbriae are regulated by CRP-cAMP regulatory complex (Båga et al., 1985; Edwards & 
Schifferli, 1997; Korea et al., 2010; Müller et al., 2009; Weyand et al., 2001). To verify the 
interactions of CRP-cAMP regulatory complex with mat operon, we purified His-tagged E. 
coli IHE 3034 CRP under native conditions and measured the direct binding of CRP to the 
pmatA and pmatB2 fragments containing the proposed binding sites and to the positive 
control fragment (placZ)  in  the  presence  of  cAMP  (Fig.  6B).  EMSA  depicted  that  the  
cAMP-CRP complex interacted with the regulatory region upstream of matA in a CRP dose-
Figure 6. Binding of cAMP-CRP to the mat upstream regulatory region and within the matB coding 
region. (A) Schematic presentation of the matAB region of IHE 3034 and DNA fragments used in 
EMSA. The three transcriptional start sites upstream of matA (T1 to T3) are indicated with right-
angled arrows. The positions of putative RcsAB and CRP boxes are shown as white and grey boxes, 
respectively, and aligment results of the matA upstream region with the consensus sequences of 
RcsAB box (Wehland & Bernhard, 2000) or CRP box (Berg & von Hippel, 1988; de Crombrugghe et 
al., 1984) are indicated. Numbering denotes the distances from the translational start site of matA or 
matB. (B) Competitive EMSA performed in the presence of pmatA and pmatB2 fragments with 
increasing concentrations (nM) of His6-CRP proteins together with 0.1 mM cAMP. The reaction 
mixtures were incubated and separated by electrophoresis at 20°C, and DNA fragments were 





dependent manner, although with lower affinity compared to the lacZ promoter, while much 
higher concentrations (2 µM) were needed to alter the migration of the pmatB2 fragment. 
The CRP-cAMP binding to the mat upstream region prompted us to construct a 
chromosomal deletion of crp gene in IHE 3034 using the method of Datsenko and Wanner 
(2000). However, we did not detect noticeable changes in the surface expression of Mat 
fimbriae in IHE 3034 crp mutant cells with and without a crp complementation plasmid 
grown in LB (assayed by ELISA) or M9 minimal media supplemented with glycerol or 
glucose (assayed by serum agglutination) compared to the parental wild type cells (data not 
shown). Thus, the in vivo role of low-affinity binding of CRP to the mat regulatory region 
remains to be elucidated.  
4.2.5 Post-transcriptional control of mat operon involves MatA-mediated stabilization 
of matB mRNA (II) 
The regulatory arrangements driving the expression of Mat fimbriae involve post-
transcriptional regulation for the control of matB transcript  levels.  Our  results  showed that  
the genes of the mat operon are sequentially transcribed from a single promoter, and the 
resulting polycistronic mRNA(s) is subject to a rapid processing event that results in the 
accumulation of a matB-coding mRNA, similar to the generation of the major fimbrillin 
transcripts of pap, sfa, cfa, and daa operons (Balsalobre et al., 2003; Bilge et al., 1993; Båga 
et al., 1988; Jordi et  al.,  1993).  The  detection  of  high  amounts  of  matB transcript but not 
other mat-specific mRNAs suggests segmental differences in stability within the 
polycistronic transcript. In E. coli, most mRNAs are rapidly degraded, and the process is 
largely triggered by RNase E-mediated endonucleolytic cleavages, followed by a rapid 3′ 
digestion by exoribonucleases, and a final finishing to mononucleotides by oligoribonuclease 
(Arraiano et al., 2010). Evaluation of matB mRNA  profile  of  the  rne131 mutant and an 
isogenic rne+ strain  IHE 3034 by  Northern  blot  analysis  (Fig.  4)  revealed  accumulation  of  
matB mRNA species in the RNase E-deficient cells indicating a role for RNase E in the 
stability of matB mRNA. 
 
mRNA decay assays demonstrated that the stability of the monocistronic matB mRNA  is  
strongly affected by temperature; the half-life was a sixfold greater at 20°C compared to that 
of 37°C (Fig. 8 and S3 of II). At low temperature of 20°C, the matB transcript is unusually 
stable with a mean half-life exceeding 38 min in exponentially growing IHE 3034 cells. 
Despite the enhanced matB mRNA steady-state levels in the rne131 mutant, the loss of 
functional RNase E delayed the turnover of the corresponding transcript only at 37°C (by 
2.6-fold to 17.6±1.6 min, p <0.002, data not shown).  
 
Sequences immediately downstream of the matB open reading frame contains two regions of 
dyad symmetry that would allow the formation of two stem-loop structures at the 3' end of 
the matB mRNA. Such secondary structures have been shown to act as protective barriers 
against 3′ exoribonucleolytic degradation (Blum et al., 1999). The processes of bacterial 
transcription  and  translation  are  coupled  events,  and  translation  can  initiate  soon  after  the  
ribosome-binding site (RBS) has been transcribed. Association of mRNA with translating 
ribosomes can greatly affect the longevity of individual mRNA, as endonucleolytic cleavage 
sites can be occluded by ribosomes (Deana & Belasco, 2005). Thus, tempereture-dependent 
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formation of secondary structures and/or enhanced translation during growth at low 
temperature, as seen for rpoS (Sledjeski et al.,  1996),  may account for the longevity of the 
matB transcript at 20°C. In contrast, at 37°C the monocistronic matB mRNA seems to be less 
protected from ribonuclease attack and is exposed to degradation initiated by RNase E. 
 
The mechanism for the differential stability of matB mRNA may involve a binding of a 
regulatory protein or a small untranslated RNA (sRNA) to the transcript. It has been shown 
that the RNA-binding factors can affect the decay rate of transcripts by e.g. accelerating 
directly RNase E–dependent degradation (Pfeiffer et al., 2009), or by affecting translational 
efficiency through a decrease in ribosome binding (Bouvier et al., 2008; Darfeuille et  al., 
2007) or disruption of an inhibitory secondary structure, that would otherwise sequester the 
ribosome-binding site (Majdalani et  al., 1998; Majdalani et  al., 2002). I showed that the 
MatA activator protein not only acts at the promoter level but also contributes to the post-
transcriptional regulation of mat operon. Ectopic overexpression of matA significantly 
increased the half-life of the processed matB mRNA  both  at  20  and  37°C  (Fig.  8  of  II).  
While the mean half-live of the matB transcript at 37°C was 6.7-6.9 min in IHE 3034 cells 
with and without the vector pACYC184, it increased about 4-fold to 29±3 min in the 
presence of plasmid carrying constitutively expressed matA. Closely resembling 
improvement of matB mRNA stability was observed in hns mutant (Fig. 11 of II). Since we 
detected an elevated matA transcript level in the H-NS deficient strain (see Chapter 4.2.3), 
the matB half-life profile of the hns matA double mutant was also determined. The loss of 
functional MatA had no effect on the stability of matB transcript in hns-deficient cells 
growing at 20°C, and at 37°C the half-life partially decreased but was still significantly 
higher (4-fold) than what was observed in the wild-type cells. These results suggest that 
MatA is not exerting its stabilizing effect on the matB mRNA through direct binding but 
rather indirectly via another regulatory protein or sRNA that stabilizes the transcript. In this 
model, H-NS decreases matB mRNA  stability  by  repressing  the  expression  of  the  RNA-
binding factor, and MatA is able to counteract this repression. When matA is overexpressed, 
in hns mutant or ectopically expressed, the expression of the RNA-binding factor is further 
enhanced. This is due to an additive effect of MatA in the activation of transcription 
initiation, either by alleviating additional repression mediated by negative regulatory factors 
other than H-NS or by acting as a classical transcriptional activator that improves the 
recruitment of the RNA polymerase to the promoter. 
 
An alternative explanation for our observations of increased matB stability in hns mutant and 
in the presence of multicopy matA is that there is too much matB transcripts (due to opened 
promoter) to be efficiently degraded, a secondary consequence of exceeding the capacity of 
RNase E. However, if this is the full explanation of the matB half-live profiles in these 
strains, we would expect similar profile in rne131 mutant. This was not the case; the loss of 
functional RNase E did not increase the half-life of matB as much as loss of H-NS or 
overproduction of MatA. However, there could be other endoribonucleases, such as RNase 




4.2.6 MatA inversely coordinates two opposite functions, Mat fimbriae-mediated 
adherence and flagella-driven motility (IV) 
During phenotypic testing of IHE 3034 matA derivatives, we noticed by phase-contrast 
microscopy that constitutive ectopic expression of matA rendered the bacterium nonmotile 
indicating that the expression of regulator MatA is linked to a flagellar system malfunction. 
Examination  of  swimming  motility  phenotypes  showed  that  matA(A536C) mutation had a 
minor positive effect on motility at 20°C both in IHE 3034 and MG1655 backgrounds, 
whereas complementation with pACYC184-derivatives carrying the matA gene from IHE 
3034 or from MG1655 severely impaired the motility at 20°C as well as at 37°C (Fig 1 of 
IV). In contrast, the co-expression of matBCDEF from the plasmid or deletion of 
chromosomal matBCDEF genes did not drastically affect the motility of IHE 3034.  
 
Northern blot and single-copy lacZ reporter analyses revealed that MatA controls motility at 
the top level of a tiered flagellar regulatory cascade by repressing the expression of the 
flagellar master operon flhDC (Fig. 2 and 3 of IV). In line with the motility phenotype, the 
inactivation of matA elicited moderately upregulated transcription initiation from the class 1 
flhDC promoter resulting increase in flhDC transcription, while in trans overexpression of 
MatA severely impaired the ability to activate the promoter and consequently resulted in 
total loss of flhDC mRNA. The expression pattern of flagellin gene fliC at the distal end of 
the cascade correlated that of flhDC.  EMSA  assays  demonstrated  a  direct  interaction  of  
MatA with the upstream region of the flhDC operon; the binding affinity was similar to that 
observed with the mat regulatory region (Fig. 4 of IV). 
 
Taken together, the results demonstrate that MatA can act beyond its local influence on the 
mat operon as an additional component of the complex regulatory network controlling 
flagellar expression. The cross-talk with flagella system is biologically important as it 
enables an inverse coordination of largely antagonistic forces, flagella-driven locomotion 
and fimbriae-mediated immobilization. Flagellar motility facilitates approach of a suitable 
surface and helps to overcome surface repulsion, and the subsequent cell-surface adhesion or 
cell-cell interaction is commonly mediated by fimbrial structures. Upon bacterial attachment 
to a surface, force-generating flagellar movement can destabilize the contact to the surface. 
Cleary and co-workers (2004) showed that flagellar synthesis of enteropathogenic E. coli 
strain E2348/69 greatly decreased in the course of microcolony formation on epithelial cells, 
and another study found that the epithelial cell adhesion of this strain led to upregulation of 
Mat fimbriae (Saldaña et al., 2009). Our results indicate that these two phenomena are 
connected by the opposite regulatory actions of MatA. 
 
To my knowledge, MatA is the first master fimbriae regulator that represses the transcription 
of flhDC operon in E. coli. The flagellar inhibition by the curli activator CsgD occurs at a 
step after class 1 transcription by repression of fliE and fliEFGH operons (Ogasawara et al., 
2011). Overexpression of P fimbriae protein PapX in UPEC (Simms & Mobley, 2008), S 
fimbriae protein SfaX in NMEC (Sjöström et al., 2009a), and MrpJ in Proteus mirabilis (Li 
et al., 2001; Pearson & Mobley, 2008) down-regulate motility but have no impact on the 
fimbriae expression. Moreover, a recent study of Reiss and Mobley (2011) indicated that the 
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effect of papX on motility involves pathogen-spesific host factors as the K-12 strain 
MG1655 remained motile when harbouring multicopy papX although the strain has an intact 
binding site for PapX in the flhD promoter.  In  this  thesis  work,  however,  motility  was  
repressed in both the pathogenic strain IHE 3034 and the non-pathogenic strain MG1655 
when matA was ectopically expressed (Fig. 1 of IV).  
 
It can be argued that the effect of MatA on motility is really seen only when the regulator is 
constitutively expressed which challenges the physiological role of this regulatory circuit. 
However, it should noted that the experiments in this thesis study describe the average 
behavior of the cells in a population and do not take into account of cell-to-cell variability. 
Mat fimbriae are synthesized in a phase-variable manner (Pouttu et al., 2001; Fig. 4 of I; see 
Fig. 7), generating phenotypic heterogeneity within the population, which can mask the 
motility effect at a population level. Approximately 10% of the cells applied for Northern 
blotting and lacZ reporter  experiments  express  Mat  fimbriae  at  20°C (Pouttu et al., 2001). 
According to Chapter 4.2.2, MatA forms a positive feedback loop in which it reinforces its 
own expression, and in turn enables the expression of the fimbria. Immunofluorescence 
microscopy analysis indicated that the variation of Mat fimbriation is significantly 
influenced by the concentration of MatA, as ectopic expression of matA resulted in a 
uniform Mat fimbriation “on” status in the culture (Fig. 7). These results are compatible with 
the model where the variability is epigenetic, in which a change in gene expression does not 
involve changes in DNA sequence, and contains a stochastic, reversible switch. The switch 
depends on the presence of positive feedback loop and determines the level of the key 
regulator MatA. Such a system can generate a bistable output, i.e. two alternative expression 
Figure 7. Indirect immunofluorescence microscopy analysis of the phase-variable Mat fimbriae.The 
parental strain IHE 3034-Rif and the matA deletion derivatives were grown in LB at 20°C, and Mat 
fimbriae were detected using anti-Mat fimbria antiserum as primary antibodies. The matA deletion 
was complemented with a pACYC184-based plasmid carrying the matA gene under the constitutive 
ptet promoter of the vector. Representative microscopy fields of epifluorescence (upper panels) and 




states among cells within an isogenic population (Dubnau & Losick, 2006; Smits et al., 
2006). This model may explain the consistent but minor effect of matA mutation on motility 
and flhDC promoter activity. More importantly, this model predicts that individual cells 
expressing Mat fimbriae are less motile, at least if the threshold levels for matA 
autoactivation and flhDC repression are similar. Thus, we hypothesize that the MatA-flhDC 
cross-talk plays a role in a transition from a motile free-living phase to a Mat fimbria-
mediated sessile growth. 
 
The flhDC connection incorporates MatA tigtly to the complex flagellar regulatory network 
via two feedforward loop circuits, RcsB-MatA-flhDC and H-NS-MatA-flhDC (Fig.  8).  The 
effect of the abundant, pleiotrophic regulator H-NS on motility is opposite to that of MatA, 
as it activates the expression of the flhDC operon (Bertin et  al., 1994) by binding to the 
regulatory region of the operon (Soutourina et al., 1999). In consequence, an hns mutant is 
nonmotile. As described in Chapter 4.2.3, H-NS represses the transcription of the mat 
operon, including the matA gene. As loss of H-NS causes upregulation of matA, the motility 
defect of an hns mutant may partially be due to the MatA-mediated repression of flhDC. 
However, the hns matA double mutant is still nonmotile (data not shown), which indicates 
that the activating effect of H-NS on flhDC is  stronger than the repressive effect  of MatA. 
Given that H-NS protein is also required for the normal flagellar motor function (Ko & Park, 
2000; Paul et al., 2011), MatA cannot solely be responsible for the locomotion deficiency of 
the hns mutant. However, the link between MatA, H-NS, and FlhDC is noteworthy as this 
circuit fits to a regulatory network motif termed the cohorent type-4 feedforward loop 
(Mangan & Alon, 2003; Fig. 7). The feedforward loop (FFL) is one of the most prevalent 
network motifs in transcription networks. In the FFL, a transcription factor X regulates the 
promoter of the gene for Y, and both X and Y regulate the promoter of target gene Z. Thus, Z 
is regulated by a direct path from X and by an indirect path through Y.  H-NS  is  able  to  
promote motility directly via binding to the flhDC promoter and indirectly by repressing the 
transcription of matA. Furthermore, MatA forms together with the Rcs phosphorelay 
regulator RcsB another cohorent feedforward loop (type-3) that influences motility (Fig. 8). 
RcsB has an opposite regulatory effect on the expression on flhDC and mat operon; it serves 
as a repressor acting in the flhDC promoter region (Francez-Charlot et al., 2003) and as an 
activator for mat. Thus, MatA and RcsB jointly inhibit flagella synthesis and promote the 
surface attached mode of growth. 
 
Figure 8. Autoregulated MatA is integrated into two 
feedforward loop (FFL) network motifs that control the 
expression of the flagellar master operon flhDC. The RcsB-
MatA-flhDC circuit is in the form of a cohorent type-4 FFL, 
and the H-NS-MatA-flhDC circuit in the form of a cohorent 
type-3 FFL. Arrowheads indicate activation while blunt 
ends symbolize repression. 
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4.2.7 Host-associated cues, acidic pH and high acetate concentration, promote Mat 
fimbriae expression at 37°C in E. coli isolates of the B2 phylogenetic group (II) 
Low temperature is the only environmental condition that was previously established to 
stimulate Mat fimbriae expression in IHE 3034 (Pouttu et al., 2001). Girón’s laboratory has 
demonstrated that diarrheagenic E. coli isolates  express  Mat/ECP fimbriae  also  at  37°C in  
the eukaryotic-cell culture medium DMEM (Avelino et  al., 2010; Blackburn et  al., 2009; 
Hernandes et al., 2011; Rendón et al., 2007; Saldaña et al., 2009), and the presence of 5% 
CO2 atmosphere  was  shown  to  further  stimulate  the  fimbriae  expression  (Rendón et al., 
2007). In order to dene those specic environmental cues that could promote Mat fimbriae 
expression in the meningitis isolate IHE 3034, I evaluated a range of laboratory conditions, 
which may be relevant to bacterial colonization of warm-blooded hosts. DMEM in the 
absence and presence of 5% CO2 had no effect on the matB transcription or surface 
expression of Mat fimbriae at 37°C by IHE 3034 (Fig. 1, 2 and S5 of II). In contrast, IHE 
3034 bacteria grown at 37°C in LB at low pH (pH 5.5) or in LB containing elevated levels of 
acetate (50-100 mM) demonstrated increased mat promoter activity, matB transcription and 
matB mRNA half-life, and the production of the Mat fimbriae (Fig. 1, 2, 9 and S5 of II). The 
presence of Mat fimbrial filaments on the bacteria after growth at acidic pH (pH 5.5) at 37°C 
is shown in Figure 9. 
 
 
Intestinal and vaginal bifidobacteria excrete large concentrations of acetate and other SCFAs 
as the major end products of carbohydrate metabolism, and I showed by serum agglutination 
that a conditioned medium of Bifidobacterium longum cells cultured in acetate-depleted 
MRS broth promotes Mat expression in IHE 3034 at 37°C. This indicates that E. coli is able 
to express Mat fimbriae at the anatomical sites, the birth canal and intestine. However, the 
Figure 9. Immunoelectron 
microscopy of Mat fimbriae. 
The strain IHE 3034-Rif and 
the Mat fimbriae-deficient 
matF deletion derivative 
harbouring pSE380 vector 
or IPTG-inducible matF 
expression plasmid were 
cultivated in LB with 0.1 M 
MES (pH 5.5) at 37°C, and 
the surface-exposed Mat 
fimbriae were labeled using 
anti-Mat antibodies and 
protein A conjugated to 10-
nm gold particles. 
Arrowheads point to 
representative gold-labeled 





host-associated cues, acidic pH and elevated levels of acetate or conditioned medium of B. 
longum did not promote biofilm formation of IHE 3034 at 37°C (data not shown).  
 
Further, I tested by whole-cell ELISA analysis whether other strains of phylogenetic group 
B2 than IHE 3034 are able to induce Mat fimbriae expression under these two host-
associated signals and/or low growth temperature (Fig. 2 of II). At 20°C in LB, each B2 
strain  was  able  to  express  the  fimbriae,  whereas  at  37°C  the  B2  strains  showed  a  
considerable degree of variation in responses to acidic pH and high acetate concentration. 
More than half of the B2 strains (7/11) expressed the fimbriae when cultured at pH 5.5, and 
several (5/11) also responded to the addition of 0.1 M acetate. In contrast, two tested B1 
strains and the A phylogroup strain MG1655 were negative for Mat fimbriation under the 
examined conditions. These results indicate that environmentally-dependent expression of 
the adhesive Mat fimbriae involves phylogenetic group -associated differences in regulation. 
Our results suggest that capability of Mat expression is a common property of B2 isolates. 
According to current classification, diarrheagenic E. coli isolates are found in various 
phylogenetic groups other than B2 (Escobar-Páramo et  al., 2004), whereas extraintestinal 
isolates cluster mainly into the B2 group (Moulin-Schouleur et al., 2007; Picard et al., 1999). 
Given that EHEC strain EDL933 express the fimbriae after growth in DMEM at either 26°C 
or 37°C, but not in LB (Rendón et al., 2007), the Mat fimbriation status seems to rely on 
different cues in diarrheagenic and extraintestinal E. coli strains and may reflect adaptation 
to specific habitats. 
4.2.8 Differential expression of the mat operon is due to polymorphisms in the mat 
regulatory region (II) 
An intact mat gene cluster is present at an identical chromosomal location in 41 out of 45 
(91%) completely sequenced E. coli genomes representing different phylogenetic groups and 
pathovars. In an attempt to identify molecular signatures associated with the differential 
expression of Mat fimbriae in subsets of E. coli, I performed a comparative nucleotide 
sequence analysis on 48 mat upstream regulatory regions, including those from publicly 
available and seven in-house sequences from the strains used in the whole-cell ELISA assay 
(see Chapter 4.2.7; and Table 7). The analysis revealed two discrete promoter lineages that 
associate with different phylogenetic groups of E. coli (Fig.  2 of II).  One promoter lineage 
contained the isolates of the phylogenetic group B2, D, and the E groups; and the other the A 
and B1 strains. In contrast, the coding regions of matA-F genes showed phylogroup-
independent sequence conservation and low degree of strain-specific polymorphisms (Fig. 
S1 and Table S1 of II). Low ratios of non-synonymous (dN, amino acid replacement) to 
synonymous (dS) silent changes in the mat genes showed characteristics of housekeeping 
genes (dN/dS<<1; Boyd & Hartl, 1998; Gomez-Duarte et al., 2007), suggesting that matA-F 
genes are evolving under strong purifying selection and purged to preserve their structure 
and function. 
 
IHE 3034 and MG1655 represent extreme cases according to the Mat surface expression and 
mat sequence analyses. In addition, multi-copy lacZ reporter analysis in IHE 3034-Rif 
background showed that the β-galactosidase activity directed by the pAMG1655-lacZ fusion, 
that encompasses 608 bp of the matA upstream region and the first 81bp of matA derived 
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from MG1655, was only 20% of the activity obtained with the pAIHE 3034 promoter fusion 
(Fig. 5 of II). This result supports the idea that the phylogroup-specific and environmentally-
dependent expression of mat genes could be assigned to the lineage-restricted 
polymorphisms in the mat regulatory region. To ascertain whether the the promoter sequence 
variation is a primary determinant of the differential mat expression, and thus the reason for 
the crypticity of the mat gene cluster in MG1655, I constructed a series of promoter 
swapping strains where mat regulatory regions were replaced between the chromosomes of 
IHE 3034 and MG1655 (Fig. 5 of II). Complete loss of fimbriation in IHE 3034 by changing 
the proximal ~350 base pairs of the upstream regulatory region, that contains the 
transcriptional start sites T1 and T2 in IHE 3034 and is almost completely conserved in 
isolates of the B2/D/E lineage, into MG1655-based sequences confirmed that the matMG1655 
promoter contains defects that disrupt the fimbriae expression. However, the replacement of 
this defective promoter region of MG1655 to the corresponding IHE 3034 sequence did not 
support Mat fimbriation in MG1655 background. In contrast, swapping of an extended 0.6 
kb upstream regulatory region containing all three transcription start points enabled crossing 
of the repression exerted by H-NS and introduced Mat fimbriation capacity into MG1655. 
This gain-of-function mutagenesis demonstrates that all mat genes are functional in MG1655 
and the strain has retained the core function of MatA to control mat expression. Taken 
together, our results reveal that the genetic basis of temperature-dependent and phylogenetic 
group –associated Mat fimbriation phenotype results mainly from cis-variations influencing 
particular promoter architecture. On the other hand, Mat expression response of B2 strains to 
acidic pH and elevated levels of acetate appears to require strain-specific transcription 
factors and/or additional regulatory elements beyond 0.6 kb mat promoter and matA.  
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5 Conclusions  
This study addressed the functional characterization of the common colonization factor Mat 
fimbriae of E. coli and the molecular mechanisms of the regulation of these surface 
appendages. The results of this thesis work give a novel example of intra-species divergent 
evolution of chromosomal regulatory DNA element that controls a common but 
differentially expressed adhesin in a bacterial species associated with various ecological 
niches or pathogenetic outcomes. We showed that the expression of the mat gene cluster of 
E. coli is favored under defined in vitro conditions exclusively by isolates of the virulence-
associated phylogenetic group B2, including the meningitis strain IHE 3034, but not by the 
phylogroup B1 and A strains, in a manner dependent on decreased temperature or the host-
niche cues acidic pH and elevated levels of acetate. The heterogeneity in Mat fimbriae 
expression likely offers selective advantage to the bacterium, and might reflect adaptation to 
specific habitats by subpopulations. Our results demonstrate that the differential expression 
of the mat operon is largely due to polymorphisms in the mat upstream regulatory region that 
falls into two main lineages associated with phylogenetic grouping of E. coli, whereas the 
coding regions of the operon are highly conserved in the genomes. We suggest that the six-
gene mat operon is an early acquisition in the evolution of E. coli and maintained across E. 
coli isolates to facilitate colonization, transmission, and survival at ecological niches that 
require differential gene expression.  
 
In this thesis work, Mat fimbria is defined as a novel determinant for temperature-dependent 
biofilm formation in E. coli.  The  protective  mode  of  growth  as  a  biofilm  represents  a  
fundamental bacterial survival strategy in changing and severe conditions (Hall-Stoodley et 
al., 2004). The primary habitat of E. coli is in the intestinal tract of warm-blooded animals, 
but the bacterium also survives and proliferates in water, sediment, and soil (Ishii et al., 
2006; Power et al., 2005; Savageau M.A., 1983; Walk et al., 2007). The ability of E. coli to 
exploit the Mat fimbria as an efficient biofilm-promoting factor on abiotic surfaces at low 
temperatures is an important phenotypic trait for adaptation and persistence outside the 
warm-blooded  host.  Moreover,  Avelino et al. (2010) showed the presence of Mat/ECP 
fimbriae on a biofilm-growing enteroaggregative E. coli (EAEC) 042 cells cultivated in 
DMEM at 37°C. Thus, biofilm formation facilitated by Mat fimbriae may also play a role in 
the host mucosal habitats of E. coli, namely the intestine and birth canal, that are dominated 
by multispecies biofilm communities (Macfarlane & Macfarlane, 2006; Macfarlane et  al., 
2011; Palestrant et al., 2004; Swidsinski et al., 2005) and contains stimulatory signals (low 
pH, high acetate concentration) for mat gene expression. Enhancement of Mat fimbriation as 
a result of acetate produced by B. longum is  an  example  of  how  bacteria  of  the  human  
microbiota affect surface structure of E. coli. 
 
The present study demonstrates that the transcriptional and post-transcriptional regulation of 
mat gene expression is complex, with overlapping regulatory circuits. Using extensive 
genetic studies, three regulators, MatA, RcsB, and H-NS, as well as endoribonuclease RNase 
E that participate in this process were identified. Based on the results of this thesis work, I 
propose a model for the mat regulatory network (Fig. 10) that allows the bacterium to 
oscillate between a motile, planktonic existence and an adherent, sessile state. In this model, 
the production of host-cell-adhesive and biofilm-promoting Mat fimbriae is promoted under 
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conditions of low temperature, acidity, or presence of acetate. MatA and RcsB act as 
activators that induce transcription initiation from the mat promoter, and their activity results 
in transcription of a polycistronic message covering matABCDEF genes. A MatA-mediated 
positive feedback loop is responsible for counteraction of H-NS –mediated repression of the 
mat locus. In addition, MatA enhances the stability of the processed matB mRNA, thus 
participating in the post-transcriptional regulation of mat expression. A second point of post-
transcriptional control is provided by the RNase E that initiates the degradation of matB 
transcript at nonpermissive conditions. To avoid simultaneous surface expression of 
adhesive Mat fimbriae and motility-enhancing flagella, MatA together with RcsB and H-NS 
forms a regulatory network that conversely coordinates these traits. When the bacterium 
initiates Mat fimbriae expression, MatA and RcsB bind to the promoter region of flagellar 
master operon flhDC, and consequently prevent flagellum synthesis, and thereby also 
motility and taxis. 
 
 
Figure 10. Model depicting the regulation of the mat expression that facilitates a motile-to-adhesive 
transition in E. coli. The mat gene cluster and flagellar master operon flhDC are linked via two 
regulatory feedforward loop circuits, RcsB-MatA-flhDC and H-NS-MatA-flhDC. Thus, the fimbriae 
activator MatA exerts a dual regulatory function on the choice of two opposite functions, Mat fimbriae-
mediated adherence and flagella-driven motility. An unstable polycistronic transcript, matABCDEF, is 
transcribed from the mat operon. The fimbrillin matB mRNA is processed from the larger precursor 
mRNA and is preferentially stabilized at low temperature, and after a temperature shift to 37°C the 
transcript becomes susceptible to RNase E-mediated degradation. In meningitis isolate IHE 3034, 
low temperature, acidic pH, and elevated levels of acetate induce Mat fimbria expression by 
activating the mat promoter and by stabilizing the fimbrillin mRNA. In addition to MatA, RcsB, and H-
NS, CRP-cAMP is able to bind to the mat regulatory DNA. The role of CRP-cAMP binding, however, 
remains open at the present. Right-angled arrows indicate transcription start sites, vertical black 
arrows show the 5’ end of monocistronic matB mRNA, and stem-loop symbols indicate the putative 
transcriptional terminators downstream of matB. Arrowheads indicate activation, and blunt ends 
indicate repression. Direct regulation is shown as continuous lines, and indirect effects are 
represented as dotted lines. 
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The regulatory model in Figure 10 provides the primary mechanisms underlying the 
expression of the mat operon. Undoubtedly, our catalogue of trans-acting factors is 
incomplete, and further studies are required to gain a coherent picture of regulatory network 
of mat system. For example, a global transcription factor Lrp has a leusine-sensitive binding 
site in the mat promoter, as discovered by ChIP-chip analysis by Cho et  al. (2008), and 
subsequent genome-wide gene expression analysis indicated that Lrp activates the 
transcription of matA in the absence of exogenous leucine. Moreover, the transcription 
factors involved in the mat promoter responses to low pH and high acetate concentration 
remains to be identified. The elucidation of adhesin protein(s) in the Mat filament, the target 
receptor(s) in the host tissues as well as the in vivo regulation of Mat expression are of the 
utmost  importance  in  order  to  better  understand  the  function  of  the  Mat  fimbriae.  Another  
interesting subject is the disruption or complete loss of mat operon in pathogenic Shigella, a 
facultative intracellular pathogen, and in a small subset of E. coli. It is tempting to speculate 
that these inactivations represent genetic trade-offs caused by antagonistic pleiotrophy. The 
evolutionary model of antagonistic pleiotropy predicts that traits beneficial for one niche are 
detrimental in another environment (Cooper & Lenski, 2000; Rose & Charlesworth, 1980). 
Thus, in the case of Shigella that invades the colonic epithelium, inactivation of the mat 
genes may be an example of pathoadaptive mutation, as seen for the lysine decarboxylase 
gene cadA (Day et al., 2001; Maurelli et al., 1998) and curli loci (Sakellaris et al., 2000), 
that results in enhanced pathogenicity. 
 
Taken together, our findings on the fine-tuned mechanisms of differential mat expression are 
important in demonstrating genomic alterations in regulatory DNA that affect regulation of 
conserved and ancestral E. coli genes important for host interactions and for living in a 
biofilm, and thus exemplify the evolution of phenotypic diversity within bacterial species. 
We are only beginning to comprehend that evolutionary adaptation to pathogenic lifestyles 
involves, in addition to gain and loss of genes, regulatory variations in expression of genes 
present both in pathogens and commensals. The data provided herein will drive the research 
on regulation of E. coli virulence and fitness factors towards a more complete understanding 
of the evolution of bacterial virulence and of the concept of pathoadaptive variation of genes 
and regulatory DNA. Considering the prevalence of mat locus in E. coli genomes, the 
adhesive-properties of Mat filaments, and the regulatory connection to the flagella system, 
we suggest that Mat-mediated cell-adhesion and biofilm formation advance the evolutionary 
success of E. coli, especially the extraintestinal isolates of the virulence-associated B2 group, 
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